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Anne-Marie Linnen, Ph.D. 
Concordia University, 2011 
 
 The nonapeptide oxytocin promotes social affiliation in both human and non-
human animals. However, the mechanisms underlying this phenomenon require further 
elucidation. There is increasing evidence that oxytocin is facilitating pro-social behaviour 
by modulating stress reactivity and social cognitive processes. Two double-blind placebo 
controlled studies were conducted to further test this theory. Study 1 examined the 
influence of intranasal oxytocin on the affective and cortisol response to the Yale 
Interpersonal Stressor (YIPS), a live social-rejection paradigm. Ninety-Six undergraduate 
students underwent the YIPS, where participants are excluded from two separate 
conversations by two same-sex confederates. Salivary cortisol levels and mood were 
repeatedly measured throughout the study. Participants were administered a single dose 
of intranasal oxytocin (24 I.U.) or placebo prior to beginning the YIPS. The YIPS elicited 
a significant negative mood response that was more pronounced in females than males. 
However, no significant cortisol response to the stressor and no sex difference in cortisol 
reactivity were observed. A significant effect of drug condition on cortisol levels was 
observed. Participants who were administered oxytocin, relative to placebo, exhibited a 
decrease in cortisol levels during the YIPS. The study ultimately revealed that oxytocin 
was effective at reducing cortisol concentrations during an interpersonal challenge.  
 iv 
The aim of study 2 was to investigate the relationship between oxytocin and basic 
emotional information processing in men and women. Eighty-four participants self-
administered 24 I.U. intranasal oxytocin or saline and later completed an assessment of 
the acoustic startle reflex with varying emotional foregrounds. Oxytocin had no impact 
on the affective modulation of the startle eyeblink response. Rather, oxytocin 
significantly diminished the acoustic startle response irrespective of the emotional 
foreground of pictorial stimuli. The results are consistent with studies showing a 
dampening effect of intranasal oxytocin on the activation of the amygdala in response to 
emotional stimuli, and further support oxytocin’s anxiolytic effects on physiological 
arousal.  
Overall, both studies demonstrate that oxytocin modulates the HPA axis during 
interpersonal challenge, and also the basic startle reflex. It is possible that by dampening 
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George Sand once wrote: "There is only one happiness in life, to love and be loved” 
(Sand, 1862). Although a ubiquitous human experience, love remains an elusive 
phenomenon. It is best understood through the relationships that are created when people 
get married, have children, make new friends etc… Although social relationships are 
often taken for granted in daily life, in the realm of psychology they are studied 
extensively. Most notably, researchers have discovered that positive social relationships 
confer important health benefits. For example, an abundant number of studies have 
demonstrated that social support increases resiliency to physical illness (Stewart & Yuen, 
2011) and represents a protective factor against the development of mental illness 
(Cohen, Hammen, Henry, & Daley, 2004; Korol, 2008). Conversely, the absence of 
positive relationships has been identified as an important factor in the pathogenesis of 
mental illness (Cohen et al., 2004; Hammen, 2003b; Hirschfeld et al., 2000; Yan, 
Hammen, Cohen, Daley, & Henry, 2004) and has been shown to have a negative impact 
on cardiovascular health (O. Evans & Steptoe, 2001; Roy, Steptoe, & Kirschbaum, 1998; 
Steptoe, 2000) as well as on health behaviours i.e. exercise, smoking, alcohol 
consumption (Allgower, Wardle, & Steptoe, 2001; Steptoe, Wardle, Pollard, Canaan, & 
Davies, 1996). In short, low social support has been linked to negative health outcomes 
(House, 2001).  
Considering the impact of positive social relationships on physical and mental 
health, significant research has been conducted to identify the neurobiological 
mechanisms regulating social affiliation (Insel, 1997). Of interest, there has been 
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overwhelming evidence implicating oxytocin (a peptide hormone) in the development of 
social behaviour across a number of different animal species (Carter, 1998). The effects 
of oxytocin on human behaviour have received considerably less attention. Measuring 
oxytocin in blood plasma is impractical because it degrades rapidly (half-life of 3 min.) 
The systematic administration of oxytocin in periphery, via oral ingestion or 
intraveniously, is also impractical because oxytocin does not readily cross the blood brain 
barrier. 
Born (2002) conducted a study that revolutionized oxytocin research in humans.  
The study examined whether intranasal peptide administration would penetrate the 
central nervous system (CNS) in healthy human males and females. One of the three 
peptides examined was vasopressin, a neuropeptide which closely resembles oxytocin in 
structure (Barberis & Tribollet, 1996). The intranasal administration of vasopressin 
resulted in a significant increase in cerebrospinal fluid (CSF) concentrations, which 
began to rise after 10 minutes, peaked at 80 minutes, and remained elevated up to 120 
minutes after administration. Considering the structural similarity between vasopressin 
and oxytocin, intranasal oxytocin has since been purported to penetrate the CNS and 
along the same time frame as intranasal vasopressin (Kosfeld, Heinrichs, Zak, 
Fischbacher, & Fehr, 2005). As a result of the experiment performed by Born (2002), the 
number of studies examining the influence of intranasal oxytocin on human behaviour 
has risen drastically in the last decade.  
Congruent with animal research, it has been fairly well established that oxytocin 
promotes social affiliation in humans (Campbell, 2010). However, the mechanisms 
underlying this relationship remain unknown. As such, the present dissertation was not 
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intended to further investigate if oxytocin modulates pro-social behaviour but was rather 
conceived to examine how the hormone exerts its pro-social effects. Before describing 
the two studies that were undertaken to address this question, we will begin by reviewing 
the existing research literature on oxytocin. More specifically, we will provide 
background information on oxytocin and will review its effects on social affiliation, 
social cognition, and stress reactivity. Despite the presence of an extensive animal 
literature on the effects oxytocin on pair bonding and maternal behavior (Insel, 2010; 
Insel, Gingrich, & Young, 2001) the present review of the literature places greater 
emphasis on research performed on humans, which we have largely drawn upon to 
conduct our own studies.  
 
1.1 Oxytocin Background 
1.1.2 Structure and Synthesis 
 
Oxytocin is a peptide hormone that consists of a sequence of 9 amino acids. It is highly 
similar in structure to vasopressin, a peptide hormone differing in only two amino acids 
(Barberis & Tribollet, 1996). It is speculated that oxytocin and vasopressin evolved from 
a common ancestral peptide called vasotocin, which controls courting sounds, sexual 
behaviour, and birthing in reptiles (Macdonald & Macdonald, 2010). Oxytocin and 
vasopressin are typically referred to as mammalian hormones and are both involved in 
the regulation of social behaviours (Heinrichs, von Dawans, & Domes, 2009). 
Oxytocin is stored in large magnocellular cells in the supraoptic nucleus and 
parventricular nucleus of the hypothalamus. From there, oxytocin is transported to the 
 4 
posterior pituitary where it is released peripherally into the bloodstream. Oxytocin is also 
synthesized and stored in smaller parvocellular cells in the paraventricular nucleus of the 
hypothalamus where it is released directly in the CNS to act on receptors in the brain and 
spinal cord regions (Carter, 1998). It is dubious to what extent the peripheral and central 
release of oxytocin is coordinated (Campbell, 2010). As such, studies of endogenous OT 
measured in blood plasma do not necessarily inform us about its central activity or 
release.  
 
1.1.3 Oxytcocin Receptors in the CNS 
 
Oxytocin’s behavioural functions depend on its ability to bind to specific receptors. 
Within the CNS, oxytocin receptors are mostly distributed in the olfactory system, 
limbic-hypothalamic system, amygdala, brainstem, and spinal cord areas that regulate 
reproductive and autonomic functions (Carter, 1998). The location and density of these 
receptors vary across species and stage of development and mediate the effects of 
oxytocin on behaviour (Insel, 1997). Variations in oxytocin receptor distribution appear 
to be associated with both transient (i.e. hormone related) and static (i.e. genetically 
determined) influences (Furman, Chen, & Gotlib, 2011; Gimpl & Fahrenholz, 2001).  
Gonadal hormones (particularly estrogen) play an important role in modulating oxytocin 
receptor expression, density, and affinity (Gimpl, Wiegand, Burger, & Fahrenholz, 2002; 
Young, Lim, Gingrich, & Insel, 2001). In female rats for example, estrogen regulates the 
expression and binding of oxytocin receptors in the ventromedial nucleus  of the 
hypothalamus, which is essential for sex behaviours (Bale, Davis, Auger, Dorsa, & 
 5 
McCarthy, 2001). Although up-regulated by estrogen, it is important to note that oxytocin 
receptors are found in both sexes. That being said, the distribution of oxytocin receptors 
can vary between sexes, thereby contributing to sexually dimorphic hormonal effects on 
behaviour (Campbell, 2008).  Identifying the mechanisms through which oxytocin 
impacts behaviour is further complicated by the fact that it and vasopressin are capable of 
binding to each others’ receptors (Barberis & Tribollet, 1996).  
 
1.1.4 Classic Functions of Oxytocin 
 
Oxytocin is well known for its reproductive functions. Oxytocin is released from the 
posterior pituitary in pulses that trigger uterine contractions during labour. During 
lactation, oxytocin contracts the myoepithelial cells surrounding the mammary glands of 
the breasts in order to produce milk letdown upon nipple stimulation. Oxytocin also 
modulates certain sexual functions. For instance, oxytocin facilitates lordosis behaviour 
in female rats and penile erection in male rats (Pfaus, 2009). In humans, plasma oxytocin 
levels have been associated with sexual arousal and have been shown to spike after 
orgasm in both men and women (Carmichael et al., 1987). However, the role of oxytocin 
on human sexual functioning requires further investigation. Apart from its role in 
reproductive functions, oxytocin is also directly involved in promoting social affiliation, 
including attachment formation and trust.  
 
1.2 Oxytocin and Social Affiliation 
1.2.1 Oxytocin and Attachment 
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There is extensive research implicating oxytocin in the neurobiology underlying 
attachment formation, including mother-infant bonding (Insel et al., 2001). The central 
administration of oxytocin has been found to stimulate maternal behaviours in rats 
(Pedersen, Caldwell, Peterson, Walker, & Mason, 1992; Pedersen, Caldwell, Walker, 
Ayers, & Mason, 1994), ewes (Kendrick, Keverne, & Baldwin, 1987) and in non-human 
primates (Holman & Goy, 1995).  
There is now evidence which corroborates these findings in humans. In a seminal 
study conducted in women, plasma oxytocin levels across pregnancy and in the post-
partum period predicted maternal behaviours (i.e. affectionate touch, “motherese”, gazing 
at infants) and mothers’ attachment representations (Feldman, Weller, Zagoory-Sharon, 
& Levine, 2007). These results have since been replicated and extended to fathers 
(Gordon, Zagoory-Sharon, Leckman, & Feldman, 2010a). Plasma oxytocin levels 
measured in fathers 6 months postpartum have been associated with paternal behaviours 
(Gordon, Zagoory-Sharon, Leckman, & Feldman, 2010b). As described previously, 
peripheral oxytocin is a poor measure of oxytocin in the CNS. The influence of intranasal 
oxytocin, which has direct effects in the CNS, was also examined on fathers’ parental 
behaviours.  Intranasal oxytocin increased fathers’ observed responsiveness to their 
children and decreased fathers’ hostility during a laboratory play session (Naber, van 
Ijzendoorn, Deschamps, van Engeland, & Bakermans-Kranenburg, 2010).  As such, it 
would appear that oxytocin is facilitating positive parenting behaviours behaviour 
postpartum in humans (Feldman, Gordon, & Zagoory-Sharon, 2011). 
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 Oxytocinegic activity appears to also be implicated in attachment bonds to 
parents (Gordon et al., 2008). Animal research indicates that oxytocin is important in the 
formation of attachment bonds in monogamous relationships. Oxytocin has been 
implicated in a gender specific mechanism for the development of pair bonding in female 
prairie voles (Cho, DeVries, Williams, & Carter, 1999). Oxytocin is released during 
copulation and interacts in specific brain regions (i.e. Nucleus Accumbens and Prelimbic 
Cortex) to facilitate partner preferences and ultimately, long lasting pair bonds (Insel & 
Hulihan, 1995; Williams, Catania, & Carter, 1992; Young et al., 2001).  
In human research, intranasal oxytocin has been observed to enhance the 
experience of attachment security among insecurely attached adults (Buchheim et al., 
2009). However, intranasal oxytocin has also been shown to negatively bias recollections 
of maternal care and closeness among anxiously attached individuals but to positively 
bias these recollections among less anxiously attached individuals (Bartz et al., 2010). It 
is therefore questionable to what extent oxytocin would enhance attachment security in 
persons with a history of unhealthy parent-child relationships. Nevertheless, oxytocin is 
released peripherally in response to “warm touch” among married couples (Holt-Lunstad, 
Birmingham, & Light, 2008). In addition, intranasal oxytocin increases positive 
communication and decreases cortisol levels during couple conflict (Ditzen et al., 2009). 
Oxytocin has further been shown to enhance perceived facial attractiveness, which could 
help to facilitate partner preferences (Theodoridou, Rowe, Penton-Voak, & Rogers, 
2009). Based on these findings, it is possible that oxytocin is involved in the formation 
and maintenance of monogamous bonds and attachment in humans. However, more 
research is needed to better identify the mechanisms involved in this process, and to 
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determine the situations  and individual dispositions that alter these relationships. The 
pro-social behavioural effects of oxytocin are not limited to social attachment. For 
example, researchers have devoted significant attention towards examining the effect of 
oxytocin on trusting behaviours in humans.  
 
1.2.2 Oxytocin and Trust 
 
There is increasing evidence that oxytocin is associated with human trustworthiness (Zak, 
Kurzban, & Matzner, 2005). Participants administered intranasal oxytocin are 
significantly more likely to entrust others with money than control participants 
(Baumgartner, Heinrichs, Vonlanthen, Fischbacher, & Fehr, 2008; Kosfeld et al., 2005) 
and to trust others even when their confidential information is at stake (Mikolajczak, 
Pinon, Lane, de Timary, & Luminet, 2010).  Oxytocin appears to be increasing trust by 
reducing fear of betrayal as opposed to increasing a general propensity to take risks 
(Baumgartner et al., 2008; Theodoridou et al., 2009). Baumgartner et al., (2008) have 
found that the amygdala plays an important role in modulating oxytocin’s effect on trust. 
They observed that during a monetary trust game, oxytocin diminished fear responses 
associated with betrayal by reducing amygdala activation and connected brainstem 
effector sites. Although oxytocin increases trust, it does not necessarily increase 
gullibility. In a recent study, oxytocin failed to increase trust in others when they were 
perceived to be unreliable (Mikolajczak, Gross, et al., 2010). Oxytocin has also been 
observed to increase trust within participants’ own “in-groups” but not towards 
competing “out-groups” (De Dreu et al., 2010). As such, oxytocin appears to foster trust 
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in contexts that are socially adaptive and that are less likely to result in aversive 
outcomes. 
In view of research highlighting the pro-social effects of oxytocin in humans, the 
mechanisms mediating these effects have been increasingly questioned. In particular, 
oxytocin has been investigated within the areas of social cognition and stress reactivity. It 
has been purported that oxytocin is promoting social affiliation by modulating how 
individuals process social information and respond to stress.  
 
1.3 Oxytocin and Social Cognition 
1.3.1 Oxytocin, Social Recognition, and Memory  
 
In non-human animals, oxytocin has been shown to impact social cognition by altering 
social memory processes and social recognition. For example, oxytocin is crucial for 
social recognition in mice (Ferguson, Aldag, Insel, & Young, 2001). In fact, oxytocin 
knockout mice fail to recognize familiar conspecifics after repeated social encounters 
(Winslow & Insel, 2002). Oxytocin appears to regulate social recognition in other species 
such as ewes (Kendrick, Keverne, Chapman, & Baldwin, 1988), prairie voles (Insel & 
Hulihan, 1995), and rats (Popik, Vetulani, & van Ree, 1992).  
Although oxytocin appears to play an important role in learning and memory in 
humans, studies have demonstrated inconsistent effects on human memory function. 
Earlier studies have reported amnesic effects of oxytocin on verbal memory processing, 
with oxytocin impairing initial storage and rate of storage (Bruins, Hijman, & Van Ree, 
1992; Fehm-Wolfsdorf, Born, Voigt, & Fehm, 1984). More recently,oxytocin was 
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observed to hinder word recall performance during an explicit memory test irrespective 
of the meaning of the word, and it selectively impaired performance during an implicit 
conceptual test by impairing the generation of associated target words for words 
associated with themes of reproduction relative to neutral meanings (Heinrichs, 
Meinlschmidt, Wippich, Ehlert, & Hellhammer, 2004).  
Opposite results have been reported with respect to emotional stimuli. Oxytocin 
was reported to improve the recognition of memory for faces, but not for non-social 
stimuli (Rimmele, Hediger, Heinrichs, & Klaver, 2009). The administration of oxytocin 
improved memory performance for facial identity (Savaskan, Ehrhardt, Schulz, Walter, & 
Schachinger, 2008), and enhanced the encoding of positive social memories (Guastella, 
Mitchell, & Mathews, 2008). It has been purported that the influence of oxytocin on 
human memory function might vary according to the memory test and the 
psychobiological relevance of the stimuli employed.  
 
1.3.2 Oxytocin and Emotional Processing 
 
Oxytocin in humans has consistently been shown to enhance emotional recognition 
(Schulze et al., 2011). However, while some studies have found that oxytocin enhances 
recognition of positive relative to negative emotional stimuli (Di Simplicio, Massey-
Chase, Cowen, & Harmer, 2009; Marsh, Yu, Pine, & Blair, 2010; Unkelbach, Guastella, 
& Forgas, 2008), others have reported that oxytocin increases recognition of negative 
relative to positive emotional stimuli (Fischer-Shofty, Shamay-Tsoory, Harari, & 
Levkovitz, 2010; Guastella, Carson, Dadds, Mitchell, & Cox, 2009). Discrepancies in 
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findings may be partly attributable to methodological differences between studies. Some 
studies have examined the effect of oxytocin at a more elaborative and conceptually 
driven (i.e. top down) stage of information processing (Di Simplicio et al., 2009; 
Unkelbach et al., 2008) whereas others have examined the effects of oxytocin at a 
perceptual (i.e. bottom-up) level (Guastella, Carson, et al., 2009; Schulze et al., 2011). 
Using an attentional shifting paradigm, oxytocin was recently found to decrease effortful 
processing of emotional faces (sad, angry) but to have no impact on automatic processing 
of emotional faces (Ellenbogen, Linnen, Grumet, Cardoso, & Joober, in press). As such, 
the effects of oxytocin on emotional recognition may vary according to the cognitive task 
being examined and to the stage of information processing it is acting at (S. Evans, 
Shergill, & Averbeck, 2010).  
Moreover, studies within this research area have employed different types of 
emotional stimuli within their paradigms (i.e. words, schematic faces, photographs of 
human faces), which further complicates comparisons between results. For instance, 
considering that oxytocin increases gaze to the eye region of human faces (Guastella, 
Mitchell, & Dadds, 2008), it is feasible that oxytocin would impact the recognition of 
human faces differently from schematic faces. In short, the effects of oxytocin on 
emotion recognition appear to be paradoxical in that it directs attention to emotional cues 
that can either signal threat or that can foster pro-social behaviour. It is possible that 
oxytocin reduces the processing of threatening social cues after the initial threat has been 
detected.   
Oxytocin appears to play a specific role in modulating fear. It has been reported to 
dampen a variety of fear responses in rodents (Windle, Shanks, Lightman, & Ingram, 
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1997) and to impact fear conditioning and extinction (McCarthy, McDonald, Brooks, & 
Goldman, 1996). Research on rats has revealed that oxytocin is gating fear responses 
through distinct neuronal outputs in the central amygdala (Viviani et al., 2011). Studies 
conducted on human males have demonstrated that oxytocin attenuates amygdala 
activation in response to emotional stimuli (Domes, Heinrichs, Glascher, et al., 2007; 
Kirsch et al., 2005; Petrovic, Kalisch, Singer, & Dolan, 2008). On the other hand, 
oxytocin has been reported to enhance amygdala activation to fearful stimuli in female 
participants (Domes et al., 2010).  
 The fact that oxytocin both enhances the processing of emotional stimuli and 
dampens brain activity in response to emotional stimuli presents an inherent 
contradiction. These differential effects appear to be mediated by different subregions of 
the amygdala (Gamer, Zurowski, & Buchel, 2010).  The administration of intranasal 
oxytocin increases amygdala activation in areas, such as the basal nucleus and superior 
colliculi, that regulate the shift of attention towards the eyes. Oxytocin decreases 
amygdala activity in nuclei (i.e. lateral amygdaloid nucleus) important for the fear and 
stress response (Gamer et al., 2010). More research is needed to examine how these 
differential effects are manifested in both males and females. 
 
1.4 Oxytocin and Stress Reactivity 
 
It has long been established that positive social interactions play a pre-eminent role in the 
behavioural and neuroendocrine response to stress (Thorsteinsson & James, 1999). In 
particular, positive relationships appear to attenuate the neuroendocrine stress response 
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associated with interpersonal challenge. For instance, among juvenile rhesus macaques, 
having a companion buffers the cortisol response that is associated with new group 
formation (Gust, Gordon, Brodie, & McClure, 1996). In humans, positive couple 
interactions diminishes the cortisol and heart rate responses to a public speech task 
(Ditzen et al., 2007), and spousal support satisfaction attenuates the cortisol response 
elicited during couple conflict (Heffner, Kiecolt-Glaser, Loving, Glaser, & Malarkey, 
2004). Although there is substantive evidence to uphold the positive effects of social 
support on stress reactivity, it is not fully understood how positive social interactions 
suppress stress-responsive physiologic systems. Because oxytocin is responsive to social 
support (Grewen, Girdler, Amico, & Light, 2005; Light, Grewen, & Amico, 2005) and 
promotes social affiliation (Carter, 1998), it has been proposed as a regulatory 
mechanism of stress reactivity (Ozbay, Fitterling, Charney, & Southwick, 2008). 
Support for this theory can be derived from research on animal models. Emotional 
stress triggers both the central and peripheral release of oxytocin in rats, suggesting that 
endogenous oxytocin might play a role in modulating stress reactivity (Engelmann, 
Ebner, Landgraf, Holsboer, & Wotjak, 1999; Windle et al., 1997). Accordingly, the 
central administration oxytocin in male rats attenuates the basal secretion of 
adrenocorticotropic releasing hormone (ACTH) and stress-induced ACTH through its 
actions in the paraventricular nucleus of the hypothalamus and the medio-lateral septum 
(Neumann, Kromer, Toschi, & Ebner, 2000; Neumann, Wigger, Torner, Holsboer, & 
Landgraf, 2000). Moreover, exogenous oxytocin appears to modulate the cardiovascular 
system (Petersson, 2002). The central administration of oxytocin in both male and female 
rats decreases blood pressure up to 10 days later (Petersson, Alster, Lundeberg, & Uvnas-
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Moberg, 1996). In addition, post-natal rats treated with exogenous oxytocin display lower 
blood pressure in adulthood (Holst, Uvnas-Moberg, & Petersson, 2002), which seems to 
indicate that oxytocin has long-term effects on cardiovascular health.  
Similar findings have been reported with respect to other species. In prairie voles, 
the central administration of oxytocin antagonists has been shown to increase basal 
cortisol (Kramer, Cushing, & Carter, 2003) whereas exogenous oxytocin has been shown 
to reduce heart rate and increase vagal regulation of the heart in response to prolonged 
social isolation (Grippo, Trahanas, Zimmerman, Porges, & Carter, 2009). Furthermore, 
exogenous oxytocin has been reported to attenuate reactivity of the HPA axis to 
prolonged social isolation in both steers and squirrel monkeys (Parker, Buckmaster, 
Schatzberg, & Lyons, 2005; Yayou et al., 2008). 
Research examining the relationship between endogenous oxytocin and stress 
reactivity in humans has yielded inconsistent results. In a study conducted by Light, 
Grewen, and Amico (2005) plasma oxytocin levels in women undergoing estrogen 
replacement therapy were positively associated with lower sympathetic activity, blood 
pressure, and vascular resistance, during a series of behavioural stressors. However, in a 
comparable sample of women, Taylor, Gonzaga, and Gian (2006) reported no 
relationship between plasma oxytocin and blood pressure in response to the same 
behavioural stressors. Moreover, plasma oxytocin levels were positively associated with 
relationship distress and elevated basal cortisol levels (Taylor et al., 2006; Taylor, 
Saphire-Bernstein, & Seeman, 2010). In accordance with these findings, elevated plasma 
oxytocin levels have been associated with anxiety over relationships (Turner, Altemus, 
Enos, Cooper, & McGuinness, 1999).  
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The contradictory findings have led to the conjecture that endogenous oxytocin 
levels might relate to stress in a bidirectional manner: oxytocin exerts stress-buffering 
effects, but is also released in response to psychosocial stressors (Tops, van Peer, Korf, 
Wijers, & Tucker, 2007). However the central mechanisms involved in such a bi-
directional relationship remain unknown.  
Several studies have examined the effect of intranasal oxytocin on measures of 
biological stress reactivity and have reported discordant findings. Oxytocin has been 
observed to increase positive communication and decrease cortisol levels during a couple 
conflict (Ditzen et al., 2009). Although these findings support the stress-buffering effects 
of oxytocin, it is important to underscore that the conflict was not considered to be 
subjectively stressful to the participants and that the task failed to elicit a significant 
cortisol response. Heinrichs, Baumgartner, Kirschbaum and Ehlert (2003) examined the 
effect of intranasal oxytocin and social support on the cortisol response to the Trier Social 
Stress Test (TSST); an achievement-related stressor consisting of a public speech task 
and mental arithmetic. Participants were randomly assigned to receive intranasal oxytocin 
or a placebo before the TSST, and either social support from their best friend during the 
speech preparation period or no social support. Oxytocin had no main effect on cortisol 
reactivity but interacted with social support to attenuate the cortisol response to the 
TSST.  
Quirin, Kuhl, and Dusing (2011) examined the influence of oxytocin on cortisol 
reactivity to a similar public speech task in individuals low and high in emotional 
regulation abilities. Oxytocin attenuated cortisol reactivity to the public speech task but 
only in participants low in emotional regulation abilities. Oxytocin alone failed to 
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modulate the cortisol response to the stressor. The effects of oxytocin were also assessed 
on other measures of stress reactivity during a public speech task, which included skin 
conductance, heart rate and blood pressure (de Oliveira, Zuardi, Graeff, Queiroz, & 
Crippa, 2011). Although oxytocin diminished skin conductance and subjective ratings of 
anxiety, it had no effect on heart rate and blood pressure during the task.  
Overall, it is possible that the effects of oxytocin on stress-responsive 
physiological systems vary depending on environmental cues and personality variables 
(Bartz, Zaki, Bolger, & Ochsner, 2011). For example, it is possible that individuals who 
have difficulty regulating their emotions during stressful situations benefit most from the 
stress-buffering effects of oxytocin (Quirin et al., 2011). It is also possible that oxytocin 
attenuates stress reactivity in certain environmental contexts but not others. The effect of 
oxytocin on stress reactivity has generally been assessed in the context of a public speech 
task, considered to be an achievement-oriented stressor. This type of psychosocial 
stressor is useful because salivary levels reliably show a 2 to 4-fold elevation in cortisol 
above baseline within 30 minutes of the stressor (Dickerson & Kemeny, 2004; 
Kirschbaum, Pirke, & Hellhammer, 1993). However, the public speech task frequently 
involves highly structured interactions with a panel of “judges” who only communicate 
according to specific directives (i.e. to keep the speech going, to start over after errors in 
mental arithmetic). Another version of the task has been employed, which simply 
involves giving a public speech in front of a video camera (de Oliveira et al., 2011; 
Quirin et al., 2011). Because oxytocin is responsive to social interactions, it is feasible 
that it would exert greater stress-reducing effects in response to an interpersonal 
challenge.  This hypothesis was investigated within our first study. 
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1.5 Research Goals 
 
As aforementioned, it has been stipulated that oxytocin is facilitating pro-social 
behaviour by modulating social cognition and stress reactivity. More specifically, it is 
believed that oxytocin is promoting social affiliation in part by altering how social 
information is processed and in part by dampening stress reactivity associated with 
social-approach behaviour. We conducted two separate studies to further test the theory. 
The aim of the first study was to assess the effects of oxytocin on the affective and 
cortisol response to the “Yale Interpersonal Stressor, a validated social rejection 
paradigm (Stroud, Salovey, & Epel, 2002; Stroud, Tanofsky-Kraff, Wilfley, & Salovey, 
2000).” Considering that oxytocin has been found to facilitate desire for social 
engagement in response to social rejection (Alvares, Hickie, & Guastella, 2010), it was 
expected that oxytocin would attenuate cortisol reactivity within the context of a similar 
interpersonal challenge. 
The aim of the second study was to examine the effect of oxytocin on emotional 
information processing, or more specifically, on the emotion modulated startle response.  
The emotion modulated startle response (described in greater detail on page 45) was 
examined because it both reliably and effectively assesses the automatic processing of 
emotional information.  Most studies have investigated oxytocin’s role in the effortful 
processing of emotional information and have yielded conflicting results. For example, 
oxytocin has been reported to enhance recognition of fearful faces (Fischer-Shofty et al., 
2010) as well as to attenuate amygdala activation in response to fearful and fear-
conditioned stimuli (Kirsch et al., 2005; Petrovic et al., 2008).  It is possible that different 
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findings would emerge with respect to the early automatic processing of emotional 
information. In the emotion modulated startle response paradigm, the magnitude of the 
eyeblink startle reflex, in response to acoustic probes, is potentiated during the viewing of 
negatively valenced emotional stimuli and attenuated during the viewing of positively 
valenced emotional stimuli. We examined if oxytocin would selectively attenuate the 
eyeblink startle response during the viewing of negative, relative to positive and neutral 
emotional stimuli. 
 In contrast to previous studies that have mostly relied on male samples, both 
studies were conducted in males and females. Each study was developed to offer its own 



























2. STUDY 1: INTRANASAL OXYTOCIN DECREASES CORTISOL LEVELS 





It is well established that chronic interpersonal stress contributes to the development of 
mental disorders (Daley, Hammen, Davila, & Burge, 1998) as well as physical illness 
(Kiecolt-Glaser, Malarkey, Cacioppo, & Glaser, 1994). Interpersonal stress, for example, 
is central to current conceptualizations of major depression (Hammen, 2003a). Moreover, 
the health disadvantages associated with interpersonal stress are often greater than of 
those related to non-interpersonal stress (Orth-Gomer & Leineweber, 2005). The 
relationship between interpersonal stress and disease may be partly mediated through the 
activation of the hypothalamic-pituitary-adrenal axis (HPA), as there is evidence that 
poor interpersonal functioning is associated with elevated cortisol levels (Decker, 2000; 
Steptoe, 1991). Chronically elevated levels of basal cortisol have negative health 
consequences, such as suppressed immunological functioning (Sapolsky, 2004). Thus, 
understanding the neurobiological regulation of interpersonal stress has important 
implications for mental and physical health. The aim of the current study was to 
investigate the role that oxytocin might play in modulating the cortisol response to 
interpersonal stress.   
 Oxytocin is a mammalian hormone that also acts as a neuromodulator in the 
central nervous system. Although well-known for its peripheral functions, which include 
stimulating uterine contractions during labour as well as milk-let down during lactation, 
oxytocin is directly involved in promoting social affiliation. In non-human mammals, 
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oxytocin has been shown to play an important role in pair-bond formation (Insel & 
Hulihan, 1995; Williams, Catania, et al., 1992; Young et al., 2001) maternal behaviour 
(Pedersen, 1997; Pedersen et al., 1994), and social recognition (Winslow & Insel, 2004). 
Studies in humans have demonstrated that intranasal oxytocin increases interpersonal 
trust (Baumgartner et al., 2008; Kosfeld et al., 2005; Theodoridou et al., 2009) and 
increases positive communication during couple conflict (Ditzen et al., 2009). Moreover, 
oxytocin has been reported to enhance the encoding of positive social memories 
(Guastella, Mitchell, & Mathews, 2008; Unkelbach et al., 2008), facilitate the recognition 
of positive facial expressions (Marsh et al., 2010), and to improve the ability to infer the 
mental states of others (Domes, Heinrichs, Michel, Berger, & Herpertz, 2007). These 
lines of research underscore the importance of oxytocinergic activity in promoting pro-
social behaviour.   
Considering that positive social interactions attenuate physiological responses to 
interpersonal stress (Ditzen et al., 2007; Heffner et al., 2004), oxytocin has been proposed 
as the regulatory mechanism of this effect. In support of this theory, oxytocin has been 
observed to impact on fear conditioning and extinction in rodents (McCarthy et al., 1996) 
and to attenuate HPA reactivity to prolonged social isolation in squirrel monkeys (Parker 
et al., 2005). Oxytocin has also been recognized to exert anxiolytic effects in humans, by 
dampening activation of the amygdala in response to both threatening and positive facial 
stimuli, (Domes, Heinrichs, Glascher, et al., 2007; Kirsch et al., 2005) as well as to 
aversely conditioned emotional responses to social stimuli (Petrovic et al., 2008). Few 
studies have examined the effects of oxytocin on the physiological stress response to 
interpersonal challenge.  Heinrichs and colleagues (2003) examined the effect of 
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intranasal oxytocin on the cortisol response to the Trier Social Stress Test (TSST), an 
achievement-related stressor consisting of a public speech task and mental arithmetic 
(Heinrichs et al., 2003). Male participants were randomly assigned to receive intranasal 
oxytocin or a placebo before the TSST, and either social support from their best friend 
during the speech preparation period or no social support. Results of the study revealed 
that social support and oxytocin interacted to suppress the cortisol response to the TSST. 
Interestingly, the direct effect of oxytocin (i.e. in the absence of social support) on 
cortisol reactivity was marginal, which may be related to the fact that the study was 
conducted solely in male participants using a social-evaluative paradigm characterized by 
highly structured interactions. Recently, intranasal oxytocin was found to increase 
positive communication and reduce cortisol levels during a couple conflict task (Ditzen et 
al., 2009). Although these findings provide evidence that oxytocin may attenuate the 
biological response to interpersonal stress the conflict was not considered to be 
subjectively stressful to the participants and there were no changes in cortisol in response 
to the task. 
The aim of the present study was to assess the effect of oxytocin on the cortisol 
and affective response to a validated interpersonal stressor in both male and female 
participants. Because most oxytocin administration studies have been conducted on male 
samples, it is imperative that similar research be conducted in women, especially in light 
of recent evidence suggesting that the effects of oxytocin on fear-related information 
processing may differ in women relative to men (Domes et al., 2010). We used the Yale 
Interpersonal Stressor (YIPS), a live social rejection paradigm known to stimulate 
negative mood change and activate the HPA axis (Stroud et al., 2000). The YIPS 
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involves two interactions with two same-sexed confederates posed as undergraduate 
students, in which the participant is made to feel excluded and isolated. In contrast to the 
TSST, the cortisol response to the YIPS has been reported to be greater in female than 
male participants, suggesting that women are more biologically reactive to interpersonal 
stress than men (Stroud et al., 2002).  To the author’s knowledge, the reported sex 
difference in the cortisol response to interpersonal stress has never been replicated. 
Therefore, a second goal of the present study aimed to replicate this important finding.   
In line with the studies conducted by Stroud et al. (2000; 2002) we predicted that 
the YIPS would induce significant negative mood change and increased cortisol levels 
relative to baseline, and that these changes would be greater among female than male 
participants. However, we hypothesized that the participants randomly assigned to 
receive oxytocin would report significantly less negative mood change and have 
significantly lower mean cortisol levels following the YIPS than participants in the 
placebo group. Given the paucity of oxytocin administration studies in women, we had 





One hundred undergraduate students, between the ages of 18 and 35, were recruited to 
participate in the study. To recruit students, advertisements were placed in the classified 
ads of McGill and Concordia Universities (Montreal, Canada) and flyers were posted on 
both campuses. Students were also recruited through classroom visits at both universities. 
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Students were excluded from participation if they smoked, consumed legal or illegal 
drugs, were not fluent English speakers, were currently ill, were suffering from either a 
chronic medical condition or major sensory impairment, or if they were ever diagnosed 
with a mental disorder. Females were excluded from participation if they were pregnant 
or believed they could be pregnant.  
Of the 100 students who participated in the study, one provided incomplete mood 
ratings during the study, and three had missing cortisol data.  As such, the final sample 
consisted of 96 participants. Forty-seven participants (24 Females/23 Males) were 
administered oxytocin and 49 were administered the placebo (24 Females/25 Males).  
 
Yale Interpersonal Stressor 
 
In accordance with the paradigm, students were informed that they were participating in a 
study assessing communication skills and were asked to engage in two separate 
conversations with two same-sexed confederates posed as fellow undergraduate students. 
The confederates then proceeded to gradually exclude the participant from each 
conversation through a series of verbal techniques and non-verbal cues. In the present 
study, confederates excluded participants in two 10 minute conversations. Both 
conversations were video-recorded and observed through a one way mirror.  
In the first conversation, participants and confederates were asked to introduce 
themselves and then to discuss “the advantages and disadvantages of living in Montreal”. 
In the first two minutes, confederates were polite in their conversation with the 
participant. However, as the conversation progressed, confederates began to engage with 
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one another more than with the participant.  At minutes three to five, confederates would 
ask each other more questions and would verbally agree with each other more than with 
the participant. They would also make greater eye contact with each other and smile and 
nod at one another more than at the participant. At minutes six to eight, confederates 
behaved in a dismissive manner towards the participant. They would interrupt the 
participant, disagree with him/her, and/or respond indifferently before resuming their 
own conversation. Confederates continued to interact positively with one another, using 
both verbal and non-verbal positive cues. For example, if the participant reported that she 
“really liked the parks in Montreal”, the confederate would reply “that’s nice” in an 
uninterested tone, and then continue conversing with the other confederate. In the last 
two minutes of the conversation, confederates ignored the participant completely. For the 
second conversation, participants and confederates discussed their hobbies.  
Confederates were undergraduate volunteers in the laboratory and were 
previously unknown to participants. Twelve confederates (3 males and 9 females) were 
used in the study. All confederates took part in 6 hours of training (3 sessions) on the 
YIPS procedures. Each experimental session was observed by one of the investigators 
(via a one-way mirror), and confederates received feedback on their performance 
immediately after each session. One –hour review sessions were also performed 
throughout the study to maintain adherence to the YIPS protocol.  
 
Materials  
Medical History Questionnaire. An in-house self-report questionnaire on participants’ 
medical history was developed to assess past and current drug use, present medical 
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problems, current medications, significant past illnesses, and drug reactions/allergies.  In 
females, the questionnaire was also used to assess phase of menstrual cycle, oral 
contraceptive use, and possible pregnancy. 
 
Profile of Mood States (POMS). The bipolar form of the POMS is a 72 item, self-report 
questionnaire that was designed to measure six bipolar mood states. Each mood state 
corresponds to a scale composed of 12 adjectives. Participants rate how they currently 
feel on a 4 point Likert scale ranging from “much unlike this” to “very much like this.” 
The POMS-bi scales are: composed-anxious, agreeable-hostile, elated-depressed; 
confident-unsure; energetic-tired; clearheaded-confused. For each scale, a low score 
reflects high ratings of negative affect and low ratings of positive affect. A high score 
reflects the opposite. The POMS takes approximately 10-15 minutes to complete. The 
authors report good test-retest reliability and construct validity (Lorr & McNair, 1988; 
Lorr & Wunderlich, 1988) and it is sensitive to mild changes in mood state (Ellenbogen, 
Young, Dean, Palmour, & Benkelfat, 1996).  
 
Bogus Social Perceptions Questionnaire (BSPQ). The BSPQ is a 12 item in-house 
inventory to assess participants’ perceptions of the two confederates they interacted with. 
It was based on the inventory used by Stroud et al. (2000). Nine items were measured on 
a five point Likert scale (i.e. this person seems friendly, this person is interesting to talk 
to, this person seems extraverted). Three items required a yes or no response (i.e. I would 
prefer to keep this person as an acquaintance, as opposed to a friend, I would like to 
know this person better, this is the type of person I might include within my social circle). 
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Participants completed the BSPQ after each conversation and for each of the two 
confederates. The use of the BSPQ helped maintain the deception of participants, who 
believed they were assessing the communication skills of fellow participants. Moreover, 





Saliva was expressed directly into polypropylene 6 ml vials. Samples were frozen at 
minus 20 ˚C until assayed for cortisol using a sensitive commercial enzyme immunoassay 
kit from Salimetrics (State College, Pensylvania; Schwartz et al., 1998). The sensitivity 
of the assay was set at 0.012 µg/dl. The inter- and intra-assay coefficient of variation for 
the assays were 2.8 % and 4.6 % (on a range of 0.01-10 µg/dl dose), respectively. 
Samples were centrifuged at 3000 RPM for 10 minutes to separate debris from saliva. 
Assays were conducted in the laboratory of Dr. C.-D. Walker at the Douglas Hospital 




Undergraduate students interested in participating in a study on “communication skills” 
were initially screened by telephone or by e-mail. Individuals meeting inclusion criteria 
were scheduled to arrive at the laboratory at either 1200h or 1445h to control for diurnal 
variations in cortisol. Participants were asked to refrain from eating, drinking (except 
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water), or exercising one hour prior to arrival at the laboratory. Upon arrival, one 
confederate was already in the laboratory and the other was cued (by cellular phone) to 
arrive several minutes after the participant. The participant and confederates were 
informed that they would be placed in separate rooms to complete questionnaires and 
undergo a relaxation phase. Each participant provided written informed consent and 
completed a Medical History Questionnaire. Eligible participants provided a first saliva 
sample and completed the bipolar form of the POMS questionnaire. In a double-blind 
randomized controlled design, each participant was administered either a single intranasal 
dose of 24 I.U. oxytocin (3 puffs per nostril; Syntocinon Spray, Novartis, Switzerland) or 
placebo (saline), via a nasal spray. Each participant then underwent a 45 minute 
relaxation phase, which involved sitting on a reclining chair and reading magazines or 
books not part of coursework and/or listening to music. A second POMS questionnaire 
was completed following the relaxation phase. Afterwards, the participant was brought to 
a common room and underwent the YIPS (see above). The experimenter informed the 
participant and confederates that they would be engaging in the first of two 10-minute 
conversations aimed at assessing communication skills in small groups. They were 
informed that their conversations would be recorded and observed live through a one-way 
mirror. At the end of the first conversation, the participant and confederates were returned 
to separate rooms and the participant provided a second saliva sample and completed a 
third POMS questionnaire as well as the BSPQ for each of the two confederates. Next, 
participants took part in the second conversation, provided a third saliva sample, and 
completed the POMS and BSPQ. Afterwards, participants provided saliva samples every 
10 minutes during a 30-minute recovery period, for a total of six samples. Participants 
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were fully debriefed and remunerated $50 for the time spent at the laboratory. All 
procedures were approved by Concordia University’s Human Research Ethic Committee. 
 
2.3 Data Analyses 
 
On the bipolar form of the POMS questionnaire, data from the six scales were summed to 
create a score for total mood change for each participant. A lower total mood score 
reflected higher ratings of negative affect and lower ratings of positive affect. Cronhbach 
alphas for the total mood scale were the following at each time point throughout the 
YIPS:  =0.83 (arrival at laboratory),  =0.85 (after relaxation phase),  =0.86 (Post-1
st
 
YIPS conversation),  = 087 (Post 2
nd
 YIPS conversation).To assess changes in mood 
over time, a 2 (sex) X 2 (drug condition) X 4 (time) repeated measures analysis of 
variance (ANOVA) was conducted on total mood scores. Chi square analyses were 
performed on the following three items of the BSPQ: “I would prefer to keep this person 
as an acquaintance, as opposed to a friend”, “I would like to know this person better”, 
“This is the type of person I might include within my social circle”, and were used to 
determine if the frequency of participants, who reported negative perceptions of the 
confederates, differed significantly from what was expected by chance. In order to 
determine if perceptions of confederates varied by sex and/or drug condition, both 
variables were entered in the chi square analysis.   
 For the cortisol data, a paired sample t-test revealed that cortisol concentrations 
were significantly higher upon laboratory arrival than after the first YIPS conversation, 
t(95) = 4.56, p < 0.05. Because the first sample tends to be subject to outside influences 
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(i.e. driving, public transport, novelty of the situation), it was excluded from the data 
analyses. Cortisol changes over time were analyzed with a 2 (sex) X 2 (drug condition) X 
5 (time) repeated measures analysis of covariance (ANCOVA), controlling for time of 
testing (1200h or 1445h). All within-subject effects were Greenhouse-Geisser corrected 
for violations of sphericity. 
 
2.4 Results 
Validity of the interpersonal stressor 
 
The BSPQ was administered to assess the effectiveness of the interpersonal manipulation. 
Following the first (second) conversation, 73% (76%) of participants reported that they 
had no interest in getting to know at least one of the confederates better, X²(1, N = 96) = 
20.17, p < 0.05 (first conversation); X²(1, N = 96) = 26.04, p < 0.05 (second 
conversation), for both confederates pooled. Eighty-six percent (90%) reported that they 
would rather keep at least one of the confederates as an acquaintance as opposed to a 
friend, X²(1, N = 96) = 51.04, p < 0.05 (first conversation); X²(1, N = 96) = 60.17, p < 
0.05 (second conversation), and 82% (83%) indicated that they would not include at least 
one of the confederates in their social circle, X²(1, N = 96) = 40.04 (first conversation), p 
< 0.05; X²(1, N = 96) = 42.67, p < 0.05 (second conversation). As expected, participants 
did not relate well to the confederates and were reluctant in getting to know them better. 
These data support the effectiveness of the YIPS in eliciting mild social rejection. 
Following the first conversation, males (98%), relative to females (76%), were 
significantly more likely to report that they had no interest in getting to know at least one 
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of the confederates better X²(1, N = 96) = 10.25, p < 0.05. No other sex differences were 
observed and there were no significant differences by drug condition. In short, the drug 
manipulation did not alter how participants perceived the confederates following both 
YIPS conversation.  
 
The Affective Response to the YIPS 
 
The Sex X Drug X Time repeated measures ANOVA revealed that mood ratings varied 
significantly across time, F(3, 276) = 21.23, p < 0.05, 
2  = 0.19 and that sex was a 
significant predictor of total mood ratings across time, F (3, 276) = 6.66, p < 0.05, 2  = 
0.07 (see Figure I). No significant main effect of drug condition, or Sex X Drug 
interaction, was found. Irrespective of sex, participants who were administered oxytocin 
reported comparable mood ratings following the YIPS as participants who were 
administered the placebo.  
To follow up the main effect of time, Bonferonni-corrected paired-sample t-tests, 
using an adjusted p-value less than 0.013, were performed between the two baseline 
measures and the two post-YIPS measures. Relative to baseline, mood ratings decreased 
significantly following the first, t(95) = 4.42, p < 0.013, d = 0.47, and second YIPS 
conversation, t(95) = 5.31, p < 0.013, d = 0.60. The decrease in mood ratings following 
each conversation was also observed with respect to mood ratings reported after the 50 
minute relaxation period, t(95) = 4.92, p < 0.013, d = 0.54 (first conversation); t(95) = 
5.41, p < 0.013, d = 0.58 (second conversation). No other significant differences were 
obtained. 
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Secondary analyses were conducted to identify the individual mood scales that 
were most sensitive to the YIPS. A Sex X Drug X Time Mood repeated Measures 
ANOVA was performed on individual mood scales of the POMS. Mood ratings varied 
significantly across time on all scales including, in the order of effect size, the agreeable-
hostile scale, F (2.07, 190.11) = 44.96, p < 0.05, 2 = 0.33, elated-depressed scale, F 
(2.40, 219.90) = 34.01, p < 0.05, 2 = 0.27, composed-anxiety scale, F (2.33, 217.00) = 
26.47, p < 0.05, 2 = 0.22, energetic-tired scale, F (2.35, 216.13) = 6.55, p < 0.05, 2 = 
0.07, confident-unsure scale, F (2.40, 221.00) = 6.17, p < 0.05, 2 = 0.06, and 
clearheaded-confused scale F (2.40, 220.93) = 3.86, p < 0.05, 2 = 0.04.  For all scales, 
mood ratings become more negative following the first and second conversations relative 
to baseline (data not shown).  Thus, mood change during the YIPS occurred across all 
POMS scales. 
 The main effect of sex was followed-up with a one way ANOVA on total mood 
ratings at each individual time point. Females reported significantly lower mood ratings 
than males after the first YIPS conversation, F (1, 94) = 5.93, p < 0.05, d = 0.50, and 
marginally lower mood ratings than males after the second YIPS conversation, F (1, 94) 
= 3.57, p > 0.05, d = 0.39, although the latter fell short of statistical significance. There 
were no significant sex differences in the mood ratings at either of the first two time 
points. 
Sex differences in mood ratings across time were found on the following individual 
scales, in the order of effect size:  energetic-tired scale F (2.35, 216.13) = 5.51, p < 0.05, 
2 = 0.06, composed-anxiety scale F (2.33, 217.00) = 4.64, p < 0.05, 2 = 0.05, 
confident-unsure scale F (2.40, 221.00) = 4.53, p < 0.05, 2 = 0.05, and elated-depressed 
 32 
scale F (2.40, 219.90) = 3.63, p < 0.05, 2 = 0.04 (data not shown).  Drug condition did 
not significantly predict mood ratings across time on any of the POMS scales.  Thus, sex 
differences in the mood response during the YIPS occurred primarily for anxious, 
depressed, tired, and unsure mood states. 
In sum, the YIPS elicited robust negative mood change following both 
conversations and across all POMS scales, and mood change was more pronounced 
among females than males. Contrary to expectation, oxytocin did not modulate the mood 
response to the YIPS, in either males or females. 
 
The Cortisol Response to the YIPS  
 
Time of day (1200h versus 1445h start time) effects on drug administration and cortisol 
levels were examined, but none were found (data not shown). The Sex X Drug X Time 
repeated measures ANCOVA, controlling for time of testing, revealed that cortisol 
concentrations did not vary significantly across time, F (4, 364) = 0.63, p > 0.64, 2 = 
0.01 and there were no significant main effect of sex, F (1, 91) = 2.97, p > 0.05, 2 = 0.03 
or sex X time interaction, F (4, 364) = 0.72, p > 0.05, 2 =  0.01 (Table I). In short, the 
YIPS failed to elicit a significant cortisol response, regardless of sex.  
The repeated measures ANCOVA revealed a significant Drug X Time interaction, 
F (4, 364) = 2.70, p < 0.05, 2 = 0.03. Because participants receiving oxytocin 
unexpectedly displayed higher cortisol concentrations at baseline (following first YIPS 
conversation; M = 0.1724, SD = 0.129) than participants receiving the placebo (M = 
0.148, SD = 0.10),  t(95) = 1.20, p > 0.05), baseline cortisol concentrations were added as 
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an additional covariate in these analyses. The Drug X Time interaction remained 
statistically significant after controlling for baseline cortisol, F (3, 273 = 3.15, p < 0.05, 
2  = 0.03, (see Figure II). A follow up repeated measures ANOVA was performed to 
assess variations in cortisol over time in each separate drug condition. Participants in the 
oxytocin condition displayed a statistically significant decrease in cortisol concentrations 
over time, F (4, 184) = 4.50, p < 0.05, 2 = 0.09 whereas participants in the placebo 
condition exhibited no change in cortisol over time, F (4, 192) = 0.29, p > 0.05, 2  = 0.00 
(see Figure II). In sum, cortisol concentrations did not increase in response to the YIPS, 
neither in male or female participants. Participants administered oxytocin, relative to 
placebo, displayed a significant decrease in cortisol concentrations throughout the YIPS. 
On the other hand, participants administered placebo, relative to oxytocin, displayed 
cortisol levels following the YIPS that were virtually unchanged from baseline. 
 
Secondary Analyses Controlling for Phase of Menstrual Cycle and Oral Contraceptive 
Use 
 
In female participants, self-reported phase of menstrual cycle  (luteal, and follicular) and 
oral contraceptive use (yes/no) were entered as covariates in Drug X Time repeated 
measures ANCOVAS conducted separately for mood ratings and cortisol concentrations. 
Because three females failed to report information on their menstruation cycle or oral 
contraceptive use on the Medical History Questionnaire, these data were performed on 45 
females. Twenty-two females were in the follicular phase, and 23 were in the luteal 
phase. Fifteen females reported using the oral contraceptive pill relative to 30 females 
 34 
who reported that they did not.  Neither phase of menstrual cycle nor oral contraceptive 





The present study examined the effect of intranasal oxytocin on the affective and cortisol 
response to the Yale Interpersonal Stressor (YIPS), a social rejection paradigm aimed at 
eliciting interpersonal stress. As expected, the YIPS elicited a robust lowering of mood in 
the full study sample, and the negative mood response was greater in women than in men. 
Moreover, we assessed the validity of the social rejection manipulation by having 
participants rate the likeableness of the study confederates. As expected, 80% or more of 
the study participants reported negative ratings of the confederates. Both of these findings 
attest to the effectiveness of the interpersonal stress manipulation. In contrast to its robust 
effects on social and emotional measures, the YIPS did not elicit an increase in cortisol 
concentrations 
 We had hypothesized that the participants receiving oxytocin would report 
significantly less negative mood change and have significantly lower mean cortisol levels 
following the YIPS than participants in the placebo group. Contrary to the hypothesis, 
oxytocin did not influence the mood response on the POMS or any of its subscales. With 
one exception (Heinrichs et al., 2003), most studies have failed to find an effect of 
oxytocin on self-report ratings of emotion (Buchheim et al., 2009; Di Simplicio et al., 
2009; Kosfeld et al., 2005). Each of the above studies investigated a single dose of 24 
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I.U. of oxytocin, indicating that dosage effects cannot account for the inconsistencies 
between studies. Despite the negative findings in this study, it is possible that the effects 
of oxytocin on mood are limited to participants who are vulnerable to mood change 
(Buchheim et al., 2009). These types of interactions have rarely been assessed in studies 
of exogenous oxytocin, and therefore warrant further research. 
In accordance with our hypothesis on HPA functioning, intranasal oxytocin 
induced decreasing cortisol concentrations during the YIPS as compared to the placebo. 
The findings are consistent with other laboratory stress inductions (Heinrichs et al., 2003) 
and suggest that oxytocin dampens the functioning of the HPA axis during different kinds 
of psychological challenge. The stress-attenuating effects of oxytocin may serve as a 
mechanism to facilitate pro-social behaviour (Heinrichs et al., 2009; Taylor, 2006). It will 
be important to determine if oxytocin attenuates HPA reactivity to non-psychological 
challenges (i.e. corticotrophin-releasing hormone and physical stress), and how oxytocin 
reaches the CNS. Although passage of oxytocin from nose to brain is likely thorough 
extraneuronal intercellular clefts in the olfactory epithelium, the exact process is not well 
delineated (Born et al., 2002). 
A second goal of the current study was to replicate previous findings reported by 
Stroud et al. (2000; 2002), which demonstrated that the YIPS induced higher cortisol 
concentrations among female compared to male participants. This finding was 
particularly influential in the literature, as it suggested that women were biologically 
more sensitive to interpersonal stress than men, with implications for understanding the 
sex difference in prevalence rates of depression (Hyde, Mezulis, & Abramson, 2008; 
Young & Korszum, 1999). The present study failed to replicate the sex difference in the 
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cortisol response to interpersonal stress. To our knowledge, no published study has 
directly replicated the result. In a study conducted by Zwolinski (2008) only females in 
the luteal phase of their menstrual cycle, and with a history of high relational 
victimization, displayed a significant cortisol response to a modified version of the YIPS. 
The lack of observed sex differences in HPA axis reactivity to laboratory stress is 
consistent with several previous studies that used other types of stress inductions (Kelly, 
Tyrka, Anderson, Price, & Carpenter, 2008; Kirschbaum, Kudielka, Gaab, Schommer, & 
Hellhammer, 1999; Stoney, Davis, & Matthews, 1987). 
Although no sex difference in cortisol concentrations was found, female 
participants reported greater negative mood change in response to the YIPS than male 
participants. These findings are consistent with research demonstrating that females 
display more negative emotional reactions to interpersonal stress in the natural 
environment than males (Hankin, Mermelstein, & Roesch, 2007; Rudolph, 2002). 
Interestingly, Stroud et al. (2000; 2002) observed no sex differences in affect ratings over 
time. The discrepancy in findings may be due to the fact that Stroud et al. (2000; 2002) 
employed visual analog scales to measure affect whereas the present study relied on the 
POMS. The original POMS questionnaire has been identified as a more sensitive measure 
of mood change than visual analog scales (Little & Penman, 1989). Alternatively, the 
sample size in the present study (n =96) was larger than the samples in the studies by 
Stroud et al. (2000; 2002; n =25; n =50 respectively), allowing for more power to detect 
group differences. It is possible that this sex difference was related to perceptions of 
confederates. Male and female participants were exposed to different sets of same-sex 
confederates, which may have contributed to sex differences in the mood response to the 
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YIPS.  Males reported a greater disinterest in the confederates than females. Perhaps, 
males engaged in external attributions of confederates (i.e. the confederates are jerks), 
whereas females engaged in internal attributions of confederates (i.e. the confederates 
don’t like me). If so, females would be expected to be more sensitive to the rejection of 
confederates and to report a greater negative mood response to the YIPS.  
A number of study limitations warrant discussion. First, the YIPS failed to elicit a 
significant cortisol response, and therefore the present study may relate to daytime 
cortisol levels but cannot readily be interpreted as demonstrating an effect of oxytocin on 
biological stress reactivity per se. Second, although participants were randomly assigned 
to receive oxytocin or placebo, a non-significant group difference in cortisol was 
observed at baseline. Therefore, it is possible that the observed decrease in cortisol over 
time, in participants who were administered oxytocin, reflected a regression towards the 
mean as opposed to an actual attenuation of the HPA axis. We addressed this possibility 
by statistically controlling for the first cortisol measure and found that the drug X time 
interaction remained statistically significant. Third, the HPA axis was the only 
physiological system that was investigated in the present study, and it is possible that the 
YIPS activated other stress-related physiological systems. Stroud (2000) had observed a 
significant increase in systolic and diastolic blood pressure in response to the YIPS. 
Although oxytocin has previously been shown to dampen the sympathetic nervous 
system in rats (Holst et al., 2002), it was recently found to have no effect on blood 
pressure or heart rate measures during a public speech task (de Oliveira et al., 2011). 
Fourth, our failure to replicate the biological sex difference in cortisol reactivity 
to interpersonal stress reported by Stroud et al. (2000; 2002) may be attributed to 
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methodological differences between studies, such as the administration of oxytocin. 
Because oxytocin attenuated the cortisol levels, separate analyses were performed in the 
placebo group (n=49) and revealed no significant sex differences in cortisol reactivity to 
the YIPS. Several procedures were implemented to replicate the YIPS, as reported by 
Stroud et al. (2000; 2002). Confederates received extensive training on the YIPS. The 
vast majority of participants (93%) reported that the confederates had deceived them. 
Because each conversation was observed live through a one-way mirror, confederates 
were given regular feedback on their performance during and after sessions to prevent 
deviations from the YIPS protocol over time. Overall, the ratings on the BSPQ were 
comparable to those reported by Stroud et al. (2000; 20002) and supported the efficacy of 
the paradigm in eliciting mild social rejection. 
Fifth, the phase of menstrual cycle varied among female participants, and 
participants using oral contraceptives were included in the study. Statistical analyses 
revealed that they had no significant influence on mood ratings or cortisol concentrations 
over time. However, menstrual cycle phase data were based on self-report and may have 
been inaccurate. It is possible that levels of circulating estrogen modulate the effects of 
oxytocin on behaviour and physiology (Gimpl & Fahrenholz, 2001). Finally, the placebo 
nasal spray used in the control condition contained a saline solution without the inactive 
compounds present in the oxytocin solution. Thus, it is possible that some of the findings 
observed in the present study could be due to the effects of a non-active compound 
administered with oxytocin. 
In conclusion, women reported a greater increase in negative affect in response to 
an interpersonal stressor than men. Although women may be more emotionally 
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responsive to interpersonal rejection than men, they exhibited no evidence of heightened 
adrenocortical reactivity to interpersonal stress, as reported previously (Stroud et al, 
2002). In addition, the results of the present study indicate that oxytocin attenuates HPA 
axis functioning during an interpersonal challenge. These results support the mediating 
role of oxytocin in the stress-protective effects of positive social interactions. In view of 
the fact that positive social relationships protect against stress-related disease (Uchino et 
al., 1999), results of the study reveal important implications for better understanding the 


















Table 1.  
 
Mean cortisol levels ( g/dl), by gender and drug condition, across 5 time points 



































































































































Note. Percentages in italics are the proportions of cortisol concentrations from baseline 
(following first YIPS conversation).   
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Figure 1. Variations in Mood across the Yale Interpersonal Stressor (YIPS), Depicted by 
Gender and Drug Condition 
 
 
Mean total mood ratings + SEM, in participants administered either oxytocin (24 
females/ 23 males) or placebo (24 females/ 25 males) at 4 separate intervals throughout 
YIPS. Total mood ratings were calculated by summing the scores on each composite 
scale of the bipolar form of the Profile of Mood States (POMS) questionnaire. Relative to 
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baseline, participants exhibited a statistically significant decrease in total mood ratings 
following the two YIPS conversations F(3, 276) = 21.23, p < 0.05, 
2 
 = 0.19, which was 
more pronounced in females than males F(3, 276) = 6.66, p < 0.05, 
2 
 = 0.07. Drug did 





















Figure 2. Variations in Cortisol Concentrations across the Yale Interpersonal Stressor 
(YIPS), Depicted by Drug Condition 
 
 
Mean cortisol levels ( g/dl) + SEM, in participants receiving oxytocin (n = 47) or 
placebo (n = 49), and across 5 time points throughout the Yale Interpersonal Stressor 
(YIPS). Participants in the oxytocin condition displayed a significant decrease in cortisol 
over time, whereas participants in the placebo condition exhibited no change in cortisol 
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concentrations over time F (4, 364) = 2.70, p < 0.05, 
2
 = 0.03, even after statistically 























3. TRANSITION TO STUDY 2 
 
The present dissertation was undertaken to investigate the mechanisms underlying 
oxytocin’s pro-social effects on human behaviour.  As described previously, oxytocin’s 
effects on behaviour may occur, in part, through changes in stress reactivity and how 
social information are processed in the environment. Thus, the objective of study 2 was to 
assess its effects on emotional information processing. The specific question being 
addressed was whether oxytocin would modulate the automatic processing of negative 
emotional stimuli. As previously mentioned, the emotion modulated startle response was 
employed as our experimental paradigm because it measures basic underlying emotional 
processes on information processing.  
  
3.1 Emotion Modulated Startle Response 
 
The startle response is a brainstem reflex that is intended to protect the back of the neck 
(whole body startle) or the eye (eyeblink) in response to sudden stimuli (Grillon & Baas, 
2003). The eyeblink startle response is typically measured using electromyography, 
which records electrical activity of the orbicularis occuli (muscle below the eye) in 
response to an acoustic probe (Blumenthal et al., 2005).  Interestingly, the magnitude of 
the eyeblink startle response can be manipulated experimentally through exposure to 
affectively valenced pictorial stimuli. Startle amplitude is highest when viewing 
negatively valenced emotional stimuli and lowest when viewing positively valenced 
emotional stimuli (Lang, Bradley, & Cuthbert, 1990; Vrana, Spence, & Lang, 1988). 
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Affective modulation of the startle response is believed to reflect aversive and appetitive 
motivational systems in the brain. Lang and Bradley (2010) have argued that the startle 
response represents a defensive system, which is enhanced during the viewing of 
negative emotional stimuli because the aversive nature of the reflex is congruent with the 
affective state, and which is attenuated during the viewing of positive emotional stimuli 
because the aversive nature of the reflex is incongruent with the affective state.  
The emotion modulated startle response has been replicated using various 
stimulus modalities such as pictures (Vrana et al., 1988), odors (Miltner, Matjak, Braun, 
Diekmann, & Brody, 1994), mental imagery (Cook, Hawk, Davis, & Stevenson, 1991), 
as well as classically-conditioned threat cues (Grillon, Chavis, Covington, & Pine, 2009). 
The emotion modulated startle response has further been found to yield moderate 
temporal stability (Larson, Ruffalo, Nietert, & Davidson, 2000).  Although a validated 
and reliable measure of emotional processing, no known human study has examined the 
effects of oxytocin on the emotion modulated startle response, or even still, on the basic 
startle reflex. Oxytocin’s influence on the startle response has received significantly more 
attention in non-human animals.  
 
3.2 Oxytocin and the Startle Response in Non-Human Animals 
 
Studies performed in non-human animals have examined the effects of oxytocin on the 
basic startle reflex and have yielded inconsistent findings. Oxytocin receptor knockout 
mice, for example, have been reported to display normal acoustic startle responses 
(Caldwell, Stephens, & Young, 2009). In rats, high doses of oxytocin have been shown to 
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have no impact on (Feifel & Reza, 1999) or to increase the startle response (King, Brown, 
& Kusnecov, 1985). In a more recent study, oxytocin, administered subcutaneously in 
rats, decreased the basic startle reflex during a fear conditioned startle response paradigm, 
but was shown to have no impact on contextually conditioned or cue conditioned fear 
(Missig, Ayers, Schulkin, & Rosen, 2010). A follow up study demonstrated that this 
effect was specific to the peripheral administration of exogenous oxytocin. When 
administered in the cerebroventricular system, oxytocin had no impact on the acoustic 
startle response (Ayers, Missig, Schulkin, & Rosen, 2011). The impact of oxytocin on the 























4. STUDY 2:  INTRANASAL OXYTOCIN ATTENUATES THE HUMAN 







Oxytocin is a nonapeptide that is produced and stored in the hypothalamus and released 
peripherally in the bloodstream as well as into the central nervous system. Within the 
central nervous system, oxytocin acts in the olfactory system, limbic-hypothalamic 
system, amygdala, brainstem, and in spinal cord areas that regulate reproductive and 
autonomic functions (Carter, 1998). Although well known for its role in parturition and 
lactation, oxytocin has also been identified as an important modulator of social behaviour 
(Williams, Carter, & Insel, 1992; Young et al., 2001). For example, oxytocin has been 
implicated in the development of pair bond formation in female prairie voles (Insel & 
Hulihan, 1995; Williams, Catania, et al., 1992) and has further been shown to activate the 
postpartum onset of maternal behaviour in rats (Pedersen, 1997), and to mediate social 
recognition in mice (Winslow & Insel, 2002). Over the past decade, oxytocin has been 
shown to promote social affiliation in humans as well. Oxytocin has been observed to 
increase trust (Baumgartner et al., 2008; Kosfeld et al., 2005; Mikolajczak, Pinon, et al., 
2010) positive communication during couple conflict (Ditzen et al., 2009) supportive 
parenting behaviours during father-infant interactions (Naber et al., 2010) and perceived 
attractiveness (Theodoridou et al., 2009) as well as to enhance the perception and 
memory encoding of positive social stimuli (Guastella, Mitchell, & Mathews, 2008).  
Oxytocin appears to facilitate social approach behaviour in part by reducing 
anxiety and neuroendocrine stress responses. Exogenously administered oxytocin has 
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been reported to exert anxiolytic effects on behaviour in rodents (Insel & Winslow, 1991; 
McCarthy et al., 1996; Windle et al., 1997). Oxytocin has also been shown to decrease 
hypothalamic-pituitary-adrenal (HPA) activity in response to social stressors (Grippo et 
al., 2009; Parker et al., 2005); an effect which has been corroborated in humans (Ditzen 
et al., 2009; Heinrichs et al., 2003; Linnen, Ellenbogen, Cardoso, & Joober, in press). 
Evidence from neuroimaging studies in humans indicates that oxytocin may be 
acting on the amygdala to impact fear processing. However, conflicting results have been 
reported. Although oxytocin has been shown to reduce amygadala activation in response 
to both fearful and fear-conditioned stimuli in male participants (Kirsch et al., 2005; 
Petrovic et al., 2008), it has also been found to attenuate amygdala responses to 
emotional faces, regardless of valence (Domes, Heinrichs, Glascher, et al., 2007). It is 
therefore unclear whether oxytocin is modulating fear processing per se or is simply 
dampening amygdala activation indiscriminately in response to social stimuli. Moreover, 
a study in female participants demonstrated that oxytocin actually enhanced amygdala 
activity in response to fearful facial expressions relative to neutral facial expressions 
(Domes et al., 2010). The discrepancies in the literature may be explained in part through 
oxytocin having opposite effects in different subregions of the amygdala (Gamer et al., 
2010). Studies of information processing have largely produced equivocal results with 
respect to the early processing of fear-related stimuli (Di Simplicio et al., 2009; 
Ellenbogen et al., in press; Guastella, Carson, et al., 2009). As such, the relationship 
between oxytocin and emotional processing appears to require further elucidation in both 
males and females.  
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The aim of the present study was to examine the effect of intranasal oxytocin on 
emotional information processing in both males and females by measuring affective 
modulation of the acoustic startle response. The acoustic startle response refers to the 
orienting of attention to a novel stimulus, such as a loud and unexpected noise. This 
response, which is automatic and involuntary, has been demonstrated across species and 
contexts (Grillon & Baas, 2003). In recent years, researchers have used an "emotion- 
modulated startle response" paradigm as a means of objectively measuring emotional 
information processing (Lang et al., 1990). The paradigm consists of the presentation of 
an emotional stimulus (i.e. an angry face, or a threatening scene), which is followed by 
the presentation of a startling stimulus, such as a loud tone. Using this simple procedure, 
the electromyographic (EMG) response in muscle below the eye (obicularis oculi) has 
been consistently shown to change in magnitude across varying emotional foregrounds 
(Vrana et al., 1988) making it an especially attractive tool with which to measure basic 
underlying emotional processes on information processing. The modulation of the startle 
response reflects the activation of defensive or appetitive brain pathways, showing 
potentiation in relation to negative, arousing environmental stimuli and attenuation in 
relation to positive, arousing emotional stimuli (Bradley, Codispoti, & Lang, 2006). As 
such, the emotional modulation of this response can give us information about individual 
differences in processing of threatening information in the environment (Yiend et al., 
2008). 
The amygdala appears to have an important role in the neural circuitry underlying 
the emotion modulated startle response. Animal models indicate three sets of neurons 
comprising startle circuitry, with one of these, the nucleus reticularis pontalis caudalis, 
 51 
receiving excitatory projections from nuclei in the amygdala (Lee & Davis, 1997). In 
rodents, electrical stimulation of the amygdala significantly enhances the acoustic startle 
reflex (Rosen & Davis, 1988). Lesion studies have also revealed that the amygdala is 
essential for fear potentiation of the startle response (Antoniadis, Winslow, Davis, & 
Amaral, 2009; Hitchcock & Davis, 1986). Similarly, work in humans indicates that the 
amygdala is involved in fear-potentiated and affectively modulated startle (Angrilli et al., 
1996; Pissiota et al., 2003). Consequently, the emotion-modulated startle response 
appears to provide an indirect measure of amygdala modulation.  
The present study examined the effect of intranasal oxytocin on the emotion 
modulated startle response using unpleasant, pleasant, and neutral stimuli selected from 
the International Affective Picture System (IAPS; Lang & Greenwald, 1988). Compared 
with pleasant and neutral stimuli, unpleasant emotional stimuli were expected to elicit the 
largest startle response. However, oyxtocin, relative to placebo, was expected to induce a 
significant decrease in startle response during the viewing of unpleasant emotional 
stimuli.  No significant group differences were expected in the pleasant and neutral 
conditions. The present study further examined the interaction between drug and gender 
on startle amplitude. However, considering the dearth of previous research examining the 






One hundred and two undergraduate students, between the ages of 18 and 30, were 
recruited to participate in the study. To recruit students, advertisements were placed in 
the classified ads of McGill University and Concordia University (Montreal, Canada) and 
flyers were posted on McGill and Concordia campuses. Students were excluded from 
participation if they smoked, were taking legal or illegal drugs, were not fluent English 
speakers, were currently ill, were suffering from either a chronic medical condition or 
major sensory impairment, or if they were ever diagnosed with a mental disorder. 
Females were excluded from participation if they were pregnant or believed they could 
be pregnant.  
Of the 102 students who participated in the study, data from 4 participants were 
excluded because of equipment failure, and 14 participants were excluded because they 
did not exhibit a measurable startle response, exhibiting mean startle amplitude lower 
than 10 V (Blumenthal et al., 2005). As such, the final sample consisted of 84 
participants. Forty-one participants were administered oxytocin (19 males/ 22 females) 
and 43 were administered the placebo (19 males/ 24 females).  
 
Materials and Design  
 
Medical History Questionnaire. An in-house medical history questionnaire was used to 
assess past and current drug use, present medical problems, current medications, 
significant past illnesses, and drug reactions/allergies. Female participants provided 
information about their menstrual cycle (to determine their current phase), and reported if 
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they were taking oral contraceptives or if they were pregnant or believed that they could 
possibly be pregnant.  
 
Pictorial Stimuli & Acoustic Probe 
 
Thirty-six pictorial stimuli were selected from the IAPS
1
 (Lang & Greenwald, 1988) and 
normative ratings from the system were used to define affective categories.  Of the 36 
pictures, 12 included negative content (i.e. mutilation, violence, tragedy, threat), 12 
included neutral content (i.e. people, common scenes, household objects) and 12 included 
positive content (nature scenes, couples, families, wealth). Visual stimuli, 1024 x 768 
pixels, were presented on a 19-in. color monitor, using the STIM visual presentation 
software (James Long Company, Caroga Lake, NY). Participants were positioned on a 
chin rest to ensure a 57 cm viewing distance. The 36 pictures were presented twice in a 
randomized order. 
The emotion-modulated startle probe protocol was administered using an 
integrated stimulus presentation and physiology recording system from the James Long 
Company (Caroga Lake, NY). Acoustic startle stimuli were presented binaurally through 
Telephonics high-impedance headphones. The acoustic startle probes were 50 ms pulses 
of 110 dB sound pressure level white noise (limited to below 4 kHz) with 0 ms rise and 




IAPS pictures used in this study were: Negative: 2205, 2683, 3005.1, 3530, 6312, 6313, 6230, 
9140, 9265, 9433, 9571; Neutral: 2038, 2102, 2435, 2485, 2580, 2593, 2594, 2595, 2597, 7190, 
7207, 7546; Positive: 2091, 2154, 4599, 4626, 4641, 5260, 5270, 5480, 5551, 5594, 5831, 8502 
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The acoustic probe was presented at 0.5 seconds, 2.5 seconds, and 4.5 seconds after 
picture onset. To reduce predictability and conditioning effects, one in four pictures was 
presented without a startle probe. 
 
Startle EMG Data Collection and Data Reduction 
 
We followed published guidelines for human startle blink studies, including subject 
presentation, electrode placement, amplification and filtering, response quantification, 
and artifact analysis and removal (Blumenthal et al., 2005). Prior to the placement of 
electrodes, the skin was prepared with an abrasive solution (NuPrep) to keep impedances 
under 10,000 . Electromyographic (EMG) activity from the orbicularis oculi muscles 
were measured from the right eye, using two Electro-Cap International Inc. (Eaton, OH) 
E21-6S 6 mm tin cup electrodes, one under the pupil and the other 2 cm lateral to the 
first, as close to the margin of the lower lid as possible (as described by Blumenthal el al., 
2005). A ground electrode was placed behind the right ear, on the mastoid. Electrodes 
were filled with high-conductivity electrode gel and affixed with adhesive collars.  
The raw EMG signal was amplified and filtered using a custom-built electrically-
isolated bioamplifiers (SA Instrumentation, San Diego, California). The raw EMG signal 
was bandpass filtered (highpass filter set at 10 Hz, low-pass filter set at 250 Hz), 
amplified (gain 4K), and were digitized on-line at a sampling rate of 1024 Hz and stored 
on hard disk for later analysis. The digitized EMG was digitally filtered off-line to 
highlight signals between 80 and 240 Hz. The data were analyzed in 75 percent 
overlapping 8 ms windows, yielding a time resolution of 2 ms. Natural blink artifacts 
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were detected using EMGART software from the James Long Company. Baseline EMG 
activity was sampled 50 ms before stimulus onset to 20 ms after stimulus onset and 
aggregated across all trials. This aggregated baseline was used to detect confounding 
natural blinks exceeding baseline. Trials with baseline periods in which the threshold was 
exceeded (greater than 2 SD above aggregate baseline mean EMG) were rejected from 
the analysis. After the deletion of trials with artefacts (less than 1.0% of the trials), the 
EMG peak amplitude between 20 ms and 200 ms post startle probe was analyzed. 
Latency from probe onset to peak EMG for each trial was also recorded, but is not 
presented here. We averaged amplitude measures across each of the nine levels of the 





Following a telephone or electronic mail screening, individuals meeting inclusion criteria 
were scheduled for testing. Upon arrival at the laboratory, participants provided informed 
consent and completed a medical history questionnaire to confirm the absence of medical 
or psychiatric disorders and other exclusion criteria. Eligible participants were then 
administered either a single intranasal dose of 24 I.U. oxytocin (3 puffs per nostril; 
Syntocinon Spray, Novartis, Basel, Switzerland) or placebo (saline), via a nasal spray. 
Drug condition was randomized across participants in a double-blind placebo-controlled 
design. Participants were instructed to clear their nostrils, and to spray three times in each 
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nostril, while sitting down. Each participant then underwent a 35-minute relaxation phase 
on a reclining chair.  
Once terminated, electrodes were affixed and participants began the EMG 
emotion-modulated startle protocol (described above). The participant was instructed to 
focus his/her attention on each picture during the entire viewing period. They were 
informed that they would hear occasional noises but were told not to pay attention to 
them. Participants viewed the 72 pictures for 6 s each with a fixed inter-trial interval of 
either 12 or 18 s. After viewing all the pictures, the electrodes were removed and 
participants performed a modified spatial cueing task and a negative priming task, which 
are presented elsewhere (Ellenbogen et al., in press) . They were then remunerated $60 




All data were analyzed using Predictive Analytics Software (PASW) version 18. Startle 
magnitude represented the primary dependent variable. Startle EMG data were collapsed 
across probe presentation latency and were z transformed within subjects in order to 
decrease between-subject variability and skew. This transformation conserved 
participants’ response patterns while ensuring that each participant contributed equally to 
the group mean, thus minimizing the influence of outliers (Patrick, Bradley, & Lang, 
1993). Standardized startle data were subject to a Drug X Sex X Picture Valence mixed 
design ANOVA. Picture valence (pleasant, neutral, unpleasant) was a within-subject 
factor. Drug condition (oxytocin, placebo) and sex were between-subject factors. Simple 
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contrasts were applied to follow up any significant within-subject effect of picture 
valence on startle amplitude. 
Because standardized data were centered on each participant’s mean (averaged 
across the 3 valence conditions), the influence of drug and sex on overall startle 
amplitude, irrespective of valence, could not be discerned from standardized data. As 
such, separate data analyses were conducted on the raw data to specifically examine main 
effects of drug and sex on startle amplitude, irrespective of stimuli valence. Data were 
subjected to a multivariate ANOVA (MANOVA). Mean startle responses, within each 
valence condition, were entered as dependent variables.  Drug and sex were entered as 
independent variables.  
 
4.3 Results 
Did emotional foreground alter the amplitude of the startle response? 
 
The Drug X Sex X Picture Valence mixed design ANOVA revealed a significant effect 
of picture valence on startle amplitude, F(2, 160) = 3.03, p < .05, 
2
 = 0.04 (see Figure 
1). According to the simple contrasts, participants exhibited significantly lower startle 
responses when viewing pleasant pictorial stimuli as opposed to both neutral F(1, 80) = 
6.68, p < .05, 
2
 = 0.08 and unpleasant pictorial stimuli F(1, 80) = 4.89, p < .05, 
2
 = 
0.05. There was no significant difference in startle amplitude during the viewing of 
unpleasant relative to neutral pictorial stimuli F(1, 80) = 0.01, p >.05, 
2
 = 0.00. Thus, 
evidence of emotional modulation of the startle response was observed with positive 
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pictures, but no evidence of modulation was found, surprisingly, for the negative pictures 
when compared to the neutral ones. 
 
Did drug or sex alter the emotion-modulated eye blink startle response? 
 
The Drug X Sex X Picture Valence ANOVA revealed no significant effects of drug 
condition, sex, or any interactions on startle amplitude.  Thus, there was no evidence of 
that oxytocin, relative to placebo, changed the emotion- modulated startle response.  
 
Did drug or sex alter the amplitude of the eye blink startle response, irrespective of 
picture valence?  
 
Using the raw data, a Drug X Sex MANOVA revealed a main effect of drug on the mean 
amplitude of the acoustic startle response F(3, 78) = 4.26, p <.05, 
2
 = 0.14. The main 
effect of sex and the Drug X Sex interaction were not significant.  Relative to placebo, 
participants who were administered oxytocin displayed significantly lower startle 
responses when viewing pleasant F(1, 80) = 9.79, p <.05, 
2
 = 0.11, neutral F(1, 80) = 
11.79, p <.05, 
2
 = 0.13, and unpleasant emotional stimuli F(1, 80) = 8.28, p <.05, 
2
 = 
0.09 (see Figure 2). In other words, participants who were administered oxytocin 
displayed an attenuation of the acoustic startle response irrespective of the emotional 






Secondary Analyses Controlling for Phase of Menstrual Cycle and Oral Contraceptive 
Use 
 
Because five female participants failed to report information on their menstruation cycle 
or oral contraceptive use on the medical history questionnaire, data analyses controlling 
for both variables were performed on a total of 41 female participants.  Nineteen female 
participants were in the follicular phase of their menstrual cycle whereas 22 were in the 
luteal phase. Fifteen female participants reported using oral contraceptives. 
 Self-reported phase of menstrual cycle (follicular, luteal) and oral contraceptive 
use (yes/no) were entered as covariates in a Drug x Picture Valence mixed design 
ANCOVA performed on standardized startle data. Both variables were also entered as 
covariates in a MANCOVA conducted on raw startle data, assessing the effect of drug on 
the amplitude of the startle response irrespective of the emotional foreground of stimuli. 
Neither phase of the menstrual cycle nor oral contraceptive use was associated with 
variations in startle amplitude for both the standardized and raw data set.  
However, when controlling for phase of menstrual cycle and oral contraceptive 
use, the main effect of drug on startle amplitude, irrespective of picture valence, fell short 
of statistical significance F(3, 35) = 2.69, p  = .06, 
2
 = 0.18. However, the magnitude of 
the effect was larger than in previous analyses conducted on the full sample. The absence 
of a significant effect was most likely related to the loss in degrees of freedom, which 







The aim of the present study was to examine the effect of oxytocin on the emotion-
modulated acoustic startle response; a methodology aimed at tapping into the activation 
defensive and appetitive motivational circuits that influence early sensory processing and 
mobilize the organism for action (Lang & Bradley, 2010). The present study had two 
main hypotheses. First, the eye blink startle response was hypothesized to be significantly 
smaller when evoked during the viewing of affectively pleasant slides and significantly 
larger when evoked during the viewing of negative slides (Bradley, Cuthbert, & Lang, 
1990; Vrana et al., 1988). Congruent with this hypothesis, pleasant emotional stimuli 
evoked significantly smaller startle responses than both neutral and unpleasant emotional 
stimuli. Contrary to the hypothesis, there was no significant difference between startle 
responses evoked during the viewing of negative and neutral stimuli. It is unclear why 
startle responses were not greater during the viewing of negative stimuli, which is in 
contrast to numerous past finding (Bradley et al., 1990; Vrana et al., 1988). It may be that 
the negative pictures, despite having robust negative ratings of valence, were not arousing 
enough to elicit activation of negative motivational brain circuits (i.e. amygdala). We did 
not include pictures of mutilation, which have among the highest ratings of arousal in 
IAPS. 
The second hypothesis stipulated that oxytocin, relative to placebo, would 
attenuate the acoustic startle response evoked during the viewing of unpleasant emotional 
stimuli but not during the viewing of neutral or pleasant emotional stimuli. This 
hypothesis was only partially supported. Relative to placebo, oxytocin significantly 
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decreased startle amplitude to an acoustic probe regardless of the affective content of the 
foreground slide presentation. That is, oxytocin dampened the actual startle reflex, but 
did not influence the affective foreground modulation of the response.  In accordance 
with our finding, a recent study demonstrated that fear conditioned rats exhibited 
diminished startle under the influence of oxytocin in both the presence and absence of the 
fear-conditioned stimulus. Oxytocin had no impact on fear-potentiated startle but 
diminished background anxiety during the startle paradigm (Missig et al., 2010).  
Our finding is consistent with a number of studies in humans showing a 
dampening effect of intranasal oxytocin on the activation of the amygdala in response to 
emotional stimuli (Domes, Heinrichs, Glascher, et al., 2007; Gamer et al., 2010; Kirsch et 
al., 2005; Petrovic et al., 2008). By dampening amygdala activation, oxytocin has been 
purported to reduce uncertainty about the predictive value of a social stimulus in order to 
facilitate social approach behaviour (Domes, Heinrichs, Glascher, et al., 2007). The 
amygdala has been shown to play an important role in the neural circuitry underlying the 
emotion modulated startle response (Angrilli et al., 1996; Pissiota et al., 2003) and to be 
directly involved in modulating the basic startle reflex in rodents (Rosen & Davis, 1988). 
It is therefore quite probable that oxytocin dampened startle amplitude by attenuating 
amygdala activation irrespective of the emotional stimuli presented. The fact that 
amygdala activation has not only been observed in response to negative emotional stimuli 
but to positive emotional stimuli as well further supports this interpretation (Yang et al., 
2007). Moreover, this explanation is consistent with findings reported by Domes et al. 
(2007) demonstrating that oxytocin attenuated right-sided amygdala responses to 
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emotional faces irrespective of the stimuli valence. Attenuation of the amygdala was not 
restricted to negative emotions but was also observed when happy faces were presented.  
 Although the amygdala represents a possible mechanism through which oxytocin 
impacted the acoustic startle response, amygdala activation was not measured in the 
present study. Consequently, we do not know if oxytocin acted on receptors in the 
amygdala to attenuate the acoustic startle response. Oxytocin may have affected other 
components of the neural circuit underlying the acoustic startle. This neural circuit is well 
documented in animals and involves three synapses located on 1) the cochler root 
neurons; 2) neurons in the nucleus reticularis pontis; 3) spinal motoneurons (Koch, 1999). 
Although there appears to be some overlap in humans, the neural pathways underlying 
the startle response in humans are not well established (Pissiota et al., 2003). As such, it 
is difficult to specify where and how oxytocin would affect these pathways. On the other 
hand, we know that the amygdala is involved in the modulation of the acoustic startle 
response (Lee & Davis, 1997) and that it contains dense concentrations of oxytocin 
receptors, which regulate its activity (Huber, Veinante, & Stoop, 2005). Using functional 
magnetic resonance imaging, future research would be required to examine if oxytocin, 
relative to placebo, reduces amygdala activation to emotional stimuli during the acoustic 
startle response.  
Alternate explanations of oxytocin’s attenuation of the acoustic startle reflex 
include possible changes in auditory sensory processing or changes in other neuropeptide 
systems that modulate the reflex (i.e. corticotropin-releasing hormone, for example). 
With respect to the former, there is animal research suggesting that oxytocin could 
modulate auditory sensory processing (Kanwal & Rao, 2002) but this effect has not been 
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observed in human research using auditory evoked potentials (Fehm-Wolfsdorf, 
Bachholz, Born, Voigt, & Fehm, 1988; Pietrowsky, Braun, Fehm, Pauschinger, & Born, 
1991). Because high levels of exogenous glucocorticoids also attenuate the acoustic 
startle reflex (Buchanan, Brechtel, Sollers, & Lovallo, 2001)  possibly through a negative 
feedback-induced decrease in the production of corticotropin-releasing hormone, it is 
possible that oxytocin is acting through interactions with this neuropeptide (Keck, Welt, 
Muller, Landgraf, & Holsboer, 2003).  Future work should address these relationships 
further, particularly the interactions between oxytocin and other neuropeptide systems. 
 Results of the present study lend further credence to the stress-reducing effects of 
oxytocin that have been previously reported in the hypothalalmic-pituitary-adrenal axis 
(Ditzen et al., 2009; Heinrichs et al., 2003; Linnen et al., in press; Quirin et al., 2011). In 
congruence with our findings, intranasal oxytocin selectively increased sympathetic and 
parasympathetic indices of autonomic cardiac control during laboratory testing (Norman 
et al., 2011). Similar beneficial effects of exogenous oxytocin administration on the 
sympathetic nervous system have been reported in rats (Holst et al., 2002). Oxytocin was 
shown to induce a long term decrease of blood pressure in rats (Petersson et al., 1996). 
Oxytocin appears to modify blood pressure and heart rate in rodents both through effects 
in the central nervous system and through its effects in other organs such as the heart, 
blood vessels, and kidneys (Petersson, 2002). Oxytocin receptor genetic variation has 
been observed to influence heart rate responses during a startle anticipation task 
(Rodrigues, Saslow, Garcia, John, & Keltner, 2009). Compared with individuals 
homozygous for the G allele of rs53576 (GG) gene, individuals with one or two copies of 
the A allele (AG/AA) exhibited greater cardiovascular activity during the startle 
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anticipation task. Taken together, these results suggest that the oxytocinergic system is 
involved in the modulation of basic physiological arousal and support the notion that 
oxytocinergic activity facilitates and maintains social contacts by modulating the 
biological stress response that is associated with social-approach behaviour (Taylor, 
2006). 
With a few exceptions (Ditzen et al., 2009; Norman et al., 2011), most studies 
examining the effects of intranasal oxytocin on human behaviour have relied on male 
samples exclusively The present study is unique for having administered intranasal 
oxytocin to both male and female participants. However, gender did not moderate the 
effect of oxytocin on the acoustic startle response. Discordant with our findings, the 
administration of intranasal oxytocin in women induced enhanced, rather than decreased, 
amygdala reactivity to fearful faces (Domes et al., 2010). In view of this finding, women 
would be expected to display a higher startle response when viewing unpleasant 
emotional stimuli, which was not observed in the present study. As such, the relationship 
between sex, oxytocin, and changes in physiological activation is more complex than 
expected. Discrepancies between studies may be due to the fact that oxytocin stimulates 
receptors in different subregions of the amygdala which has different effects on neural 
activity and behavior (Gamer et al., 2010). Oxytocin decreases activation of the lateral 
and dorsal regions of the anterior amygdala, but increases activation in posterior 
amygdala. The former is believed to be related to decreases in fear arousal, while the 
latter is associated with reflexive shifts of attention to the eye region of the face. Thus, 
our results are interpreted as providing further evidence that oxytocin plays a role in 
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decreasing physiological arousal in both men and women (Ditzen et al., 2009), which is 
likely related to specific regions of the amygdala and their associated neural circuits. 
The present study has several limitations, which warrant discussion. First, because 
oxytocin dampened the startle response independent of emotion modulation, oxytocin 
appeared to have decreased startle responses to affective stimuli in general. However, 
within our paradigm, there were no instances in which the acoustic probe was not 
preceded by a picture. It is therefore not known whether oxytocin would have attenuated 
the acoustic startle reflex in the absence of foreground pictures.  There is evidence to 
suggest that oxytocin exerts differential effects on amygdala reactivity depending on the 
stimuli presented. For example, a greater reduction of amygdala activation has been 
reported when socially relevant stimuli are presented (Petrovic et al., 2008). However, the 
attenuation of the startle reflex following oxytocin administration was equally strong 
during neutral foreground trials as it was during the emotional foreground trials. 
Moreover, Buchanan and colleagues (2001) have reported equivalent attenuation of the 
acoustic startle reflex after the administration of 20 mg of hydrocortisone during the 
presentation of startle probes with (experiment 2) and without (experiment 1) an 
emotional foreground. Still, future work in this area should include trials where an 
acoustic probe is presented in the absence of foreground emotional stimuli. 
Second, phase of menstrual cycle varied among female participants, and 
participants using oral contraceptives were included in the study. Considering that 
gonadal hormones influence the oxytocinergic system (Gimpl et al., 2002; Ochedalski, 
Subburaju, Wynn, & Aguilera, 2007), it is possible that they moderated the effect of 
oxytocin on the startle response in women. However, we conducted data analyses 
 66 
controlling for the effects of self-reported phase of menstrual cycle and oral contraceptive 
use and observed that they had no impact on our findings. Subsequent studies could 
assess levels of gonadal hormones to better examine the nature of the interaction. It is 
conceivable that gonadal hormones may have the dual function of interacting with 
exogenous oxytocin to either increase threat perception (Domes et al., 2010) or decrease 
physiological arousal (Ditzen et al., 2009). 
Third, our placebo was comprised of saline. It would have been preferable to 
employ a placebo containing all inactive ingredients of synthetic oxytocin (syntocinon) in 
order to further isolate the effects of the oxytocin molecule.  
In sum, the present study demonstrated that intranasal oxytocin attenuated the 
acoustic startle response, independent of emotion modulation. The acoustic startle reflex 
is construed as a defensive response, associated with neuropsychological components of 
avoidance and escape behaviour. By dampening the acoustic startle response, oxytocin 
appears to be reducing physiological arousal associated with threat perception, which 


















Figure 1.  Mean Startle Amplitude (Z-Transformed Data) during Exposure to Affectively 
Valenced Stimuli 
 
 Mean startle amplitude + SEM (z-transformed data) evoked during the viewing of 
pleasant, neutral, and unpleasant emotional stimuli in healthy male (n = 36) and female 
participants (n = 46). Within the overall sample, startle amplitude was significantly lower 
during the viewing of pleasant relative to both neutral F(1, 80) = 6.68, p < .05, 
2
 = 0.08  
and negative pictorial stimuli F(1, 80) = 4.89, p < .05, 
2
 = 0.05.  There was no 
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significant difference in startle amplitude during the viewing of negative relative to 
neutral pictorial stimuli. Drug condition had no significant effect on the modulation of the 






















Figure 2. Mean Startle Amplitude During Exposure to Affectively Valenced Stimuli, 
Depicted by Drug Condition  
 
 
Mean startle responses (in V) + SEM evoked during the viewing of pleasant, neutral, 
and unpleasant pictorial stimuli in healthy male and female participants. Relative to 
placebo, intranasal oxytocin induced a significantly lower startle response during the 
viewing of all pictorial stimuli F(3, 78) = 4.26, p <.05, 
2




5. GENERAL DISCUSSION  
 
Oxytocin is a hormone that promotes social affiliation across various species, including 
humans (Campbell, 2010). The aim of the present dissertation was to investigate the 
mechanisms underlying oxytocin’s pro-social effects in humans. More specifically, we 
investigated the role that oxytocin plays in regulating stress reactivity and rudimentary 
emotional information processing in healthy male and female participants. In study 1, we 
examined the effects of oxytocin on the cortisol and mood response to the YIPS, a social 
rejection paradigm. In study 2, we examined oxytocin’s influence on the emotion 
modulated acoustic startle response. Several key findings emerged from these studies. 
Results of study 1 revealed that oxytocin decreased cortisol levels during the YIPS, even 
though the YIPS failed to elicit a significant cortisol response. The YIPS did elicit a 
negative mood response, that was more pronounced in females than males, and that was 
unaltered by intranasal oxytocin. Results of study 2 revealed that oxytocin attenuated 
participants’ acoustic startle responses independent of emotion modulation. That is, 
oxytocin did not have an influence on the defensive orienting reflex activated when 
viewing aversive stimuli. Rather, oxytocin attenuated the basic orienting reflex to an 
acoustic probe, regardless of pictures presented in the foreground.   
These findings are congruent with research demonstrating that oxytocin dampens 
stress-responsive physiological systems (Holst et al., 2002; Parker et al., 2005; Petersson 
et al., 1996; Yayou et al., 2008), attenuates amygdala activation (Domes, Heinrichs, 
Glascher, et al., 2007; Kirsch et al., 2005; Petrovic et al., 2008), and exerts anxiolytic 
effects on behavior in animal studies (Grippo et al., 2009; McCarthy et al., 1996; Windle 
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et al., 1997). In other words, results of both studies further support the role of the 
oxytocinergic system in the modulation of neural pathways associated with fear, stress, 
and anxiety.  
From an evolutionary perspective, oxytocin may serve an adaptive function by 
inhibiting threat perception and basic physiological arousal associated with social 
approach behaviour. Evolutionary theory suggests that the oxytocinergic system was 
originally developed to help motivate maternal care crucial for the survival of altricial 
species (Pedersen, 2004). In these species, infants are helpless at birth; they depend on 
their mothers’ milk and bodily warmth. To ensure survival, a new motivational system in 
the brain was needed to incite sustained maternal care (Seltzer, Ziegler, & Pollak, 2010). 
In order to foster pro-social behaviour, evolution had to offset asocial inclinations 
associated with an older defence system relying on sympathetic fight or flight circuits 
(Macdonald & Macdonald, 2010). This defence system was developed to increase fear, 
risk aversion, and distrust. The oxytocinergic system was evolutionarily conserved, in 
part, because it helped to induce a state of calm and security within the context of social 
relationships. A dynamic interplay evolved between both systems, thereby ensuring 
greater safety and providing homeostasis to the organism.  
Conceptualized somewhat differently, Taylor (2006) contended that humans 
evolved a stress response not only dependant on fight or flight mechanisms, but also on 
the tendency to affiliate- that is to come together in groups to provide and receive joint 
protection from potential threat. Taylor (2006) referred to this process as “tend and 
befriend.” From Taylor’s standpoint, endogenous oxytocin is released in response to 
stressors and serves as an impetus to develop positive social relationships. These 
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relationships are associated with increases in oxytocinergic activity and attenuated 
stress/fear responses. Although perhaps too simplistic a theory, it is plausible that 
oxytocin’s stress buffering/anxiolytic effects represent one mechanism through which the 
hormone modulates social behaviour. The evolutionary upshot of this system appears to 
have been the development of social relationships that are integral for survival.   
The function of oxytocin in human behaviour, however, may be more complex 
than originally thought. The oxytocinergic system is not immutable with fixed functions.  
Rather, the system is adaptable and is influenced by individual characteristics and 
environmental factors (Bartz, Zaki, et al., 2011). In fact, oxytocin’s actions largely 
depend on the individual and/or context. For example, although several studies have 
demonstrated that oxytocin increases trust in humans (Baumgartner et al., 2008; Kosfeld 
et al., 2005; Mikolajczak, Pinon, et al., 2010), this effect is negated when the person 
potentially being trusted is perceived as untrustworthy (Mikolajczak, Gross, et al., 2010) 
or is part of a competing social “outgroup”(De Dreu et al., 2010). Moreover, oxytocin has 
actually been shown to decrease trust in participants diagnosed with borderline 
personality disorder (Bartz, Simeon, et al., 2011) a disorder characterized by 
interpersonal difficulties often related to trust. It is therefore probable that oxytocin’s pro-
social effects cannot be generalized to everyone or to every situation.  
Bartz, Zaki, Bolger and Ochsner (2011) have argued that an interactionist 
approach could further our understanding of oxytocin’s behavioural effects. They have 
contended that many of the discordant findings reported in the human literature could 
result from the fact that situational factors and/or individual variables are frequently 
ignored. For instance, we know that oxytocin both enhances emotion recognition (Di 
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Simplicio et al., 2009; Guastella, Carson, et al., 2009) and dampens amygdala activation 
in response to emotional stimuli (Domes, Heinrichs, Glascher, et al., 2007; Kirsch et al., 
2005; Petrovic et al., 2008). These contradicting effects appear to be mediated by 
different subregions in the amygdala (Gamer et al., 2010). However, little is known about 
the conditions that facilitate oxytocin’s effects in one subregion relative to another. It is 
feasible that oxytocin’s actions are responsive to environmental cues, as suggested by 
Taylor (2006). Oxytocin might feasibly attenuate amygdala activation in a non-
threatening situation but enhance recognition of negative emotions in a more dangerous 
context (Fischer-Shofty et al., 2010).   
Individual moderators could also influence the effects of oxytocin on fear and 
anxiety. For example, although we demonstrated that oxytocin attenuated the acoustic 
startle response independent of emotion modulation, individual factors (i.e. personality 
traits, affect, genes) may have moderated the magnitude of this effect across participants. 
Accordingly, genetic variance in the oxytocin receptor has been associated with heart rate 
responses to a startle anticipation task (Rodrigues et al., 2009) and with amygdala volume 
(Furman et al., 2011). It is therefore conceivable that polymorphisms in the oxytocin 
receptor gene could alter the impact of the hormone on physiological arousal, (i.e. startle 
reflex), and on fear responses.  
Research examining oxytocin’s effects on stress reactivity also supports an 
interactionist approach. Heinrichs, Baumgartner, Kirschbaum and Ehlert (2003) observed 
that oxytocin decreased the cortisol response to the TSST, but only in individuals 
receiving social support from a friend. Moreover, Quirin, Kuhl, and Dusing (2011) 
reported that oxytocin decreased the cortisol response to a public speech task but only in 
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individuals with low emotional regulation abilities. It is possible that individuals with a 
greater vulnerability to stress benefit more from the stress-reducing effects of oxytocin. 
In support of this theory, oxytocin was reported to reduce subjective ratings of anxiety 
during the YIPS but only in females with maladaptive coping abilities (Cardoso, Linnen, 
Ellenbogen, & Joober, in press). Oxytocin was also found to exert a more robust 
dampening effect on the cortisol response to the TSST in participants diagnosed with 
borderline personality disorder relative to control participants (Simeon et al., 2011).  
Given the attenuating effects of oxytocin on amygdala activation and on stress-
responsive physiological systems, oxytocin has been examined as a potential therapeutic 
agent for the treatment of anxiety disorders. Research that has been undertaken to 
examine a biological basis for oxytocin in relation to anxiety disorders has yielded 
equivocal results. Studies have shown that patients diagnosed with obsessive-compulsive 
disorder (OCD) show no improvement in compulsive, depressive, or anxiety symptoms 
when administered intranasal oxytocin over several weeks (den Boer & Westenberg, 
1992; Epperson, McDougle, & Price, 1996). In patients diagnosed with social anxiety 
disorder, intranasal oxytocin administered weekly, as an adjunct to exposure therapy, had 
no impact on either the short or long term clinical outcomes (Guastella, Howard, Dadds, 
Mitchell, & Carson, 2009).  However, intranasal oxytocin was shown to attenuate 
amygdala activation to fearful stimuli in patients diagnosed with generalized anxiety 
disorder (Labuschagne et al., 2010). In view of these findings, it would appear that 
oxytocin does not play a global role in the treatment of anxiety disorders (Striepens, 
Kendrick, Maier, & Hurlemann, 2011) but that it could be employed to mitigate fear 
responses.  
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Our research suggests that oxytocin might play a more relevant role in the 
treatment posttraumatic stress disorder (PTSD). PTSD is a mental disorder with a lifetime 
prevalence of approximately 8% (Kessler, Sonnega, Bromet, Hughes, & Nelson, 1995). 
PTSD is developed following a traumatic event and is characterized by a pervasive 
difficulty regulating stress/anxiety, particularly in situations reminiscent of the trauma. 
Studies have shown that individuals diagnosed with PTSD exhibit exaggerated 
physiological reactivity when exposed to cues associated with the trauma. In particular, 
they display enhanced sympathetic arousal (Bedi & Arora, 2007), amygdala hyperactivity 
(Francati, Vermetten, & Bremner, 2007; Koenigs & Grafman, 2009), and heightened 
startle responses (Jovanovic et al., 2010). Moreover, the HPA axis is deregulated in 
PTSD. Patients exhibit low basal cortisol levels and a heightened cortisol response to 
psychosocial stress (Bremner, Vermetten, & Kelley, 2007; Gola et al., in press). Because 
of their difficulty regulating stress/anxiety, individuals suffering from PTSD actively 
avoid both external and internal cues associated with the trauma.  
Olff, Langeland, Witteveen, and Denys (2010) put forth a psychobiological 
rationale for oxytocin as an adjunct to cognitive behavioural therapy in the treatment  of 
PTSD. Cognitive behavioural interventions are presently geared towards extinguishing 
fear responses to the trauma through exposure to fear conditioned stimuli. Because 
oxytocin has been shown to attenuate sympathetic arousal, amygdala activation, and HPA 
reactivity, the authors theorized that it could facilitate treatment by reducing fear and 
stress responses during both cognitive and behavioural exposure. The fact that oxytocin 
decreased the acoustic startle response in our study provides further evidence that it could 
dampen physiological arousal during an exposure-based treatment.  
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Providing empirical support for this theory is a study conducted in male Vietnam 
veterans diagnosed with PTSD (Pitman, Orr, & Lasko, 1993). Participants receiving 
intranasal oxytocin, relative to vasopressin and placebo, displayed reduced physiological 
responses (blood pressure, heart rate, skin conductance) during the viewing of personal 
combat imagery. Oxytocin, however, had no influence on emotional reactions to the 
combat imagery. This finding is not surprising when considering that intranasal oxytocin 
has rarely been found to influence mood in healthy participants (Ditzen et al., 2009; 
Kirsch et al., 2005). Rather than alter maladaptive emotional responses associated with 
PTSD, oxytocin may simply be more effective at targeting specific symptoms of the 
disorder, those that are perhaps more physiologically related.  
Ultimately, more research is needed to assess oxytocin’s therapeutic effects in the 
treatment of PTSD. Considering that PTSD is 2-3 times more likely to afflict women than 
men (Olff, Langeland, Draijer, & Gersons, 2007), clinical trials would need to be 
conducted in both genders. In our own research, sex did not moderate the effects of 
oxytocin on cortisol levels or the acoustic startle response. As such it is possible that 
females diagnosed with PTSD would benefit from the hormone’s anxiolytic properties.  
However, we can only speculate as to how females would respond to the hormone in 
view of the fact that human studies on oxytocin have mostly been conducted in male 
participants only.  
 Females have largely been excluded from human studies on oxytocin because 
female sex hormones (i.e. estrogen and progesterone) are known to influence the 
oxytocinergic system. (Gimpl et al., 2002). Sexually dimorphic effects of oxytocin have 
been reported in the animal literature. In prairie voles for example, the hormonal 
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mechanisms regulating pair bond formation are sexually dimorphic. Partner preference 
formation is facilitated by oxytocin in females and by vasopressin in males (Insel & 
Hulihan, 1995). Sexually dimorphic effects of oxytocin are largely steroid dependent 
and/or mediated by reproductive and somatosensory interactions (Witt, 1997).   
Sex differences represent a research area that warrants further research in humans 
as well.  It is possible that sexually dimorphic effects would emerge with respect to 
certain behavioural outcomes but not with others. For example, oxytocin exerts sexually 
dimorphic effects on reproductive behaviours in rats (Bale et al., 2001) but has similar 
anxiolytic effects in both sexes (Neumann, Wigger, et al., 2000; Petersson et al., 1996).  
Considering that gonadal hormones play an important role in modulating oxytocin 
receptor expression, density, and affinity (Gimpl & Fahrenholz, 2001), the relationship 
between gonadal hormones and oxytocin requires further investigation in human females. 
Plasma oxytocin levels have been observed to vary throughout the menstrual cycle with 
oxytocin levels peaking during ovulation and remaining elevated until menstruation 
(Mitchell, Haynes, Anderson, & Turnbull, 1981). In our own studies, we statistically 
controlled for phase of menstrual cycle and our results remained unchanged. However, it 
would be interesting to examine if the effects of oxytocin on female behaviour are 
potentiated during ovulation or are more pronounced in the luteal relative to the follicular 
phase. For greater accuracy, circulating levels of gonadal hormones would need to be 
measured rather than relying on females’ self-reported phase of menstrual cycle.  Better 
understanding these interactions would serve to explain sex differences as opposed to 
continuously avoiding them with studies consisting solely of male samples.   
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By and large, the brain mechanisms underlying oxytocin’s 
behavioural/physiological effects require further investigation in humans. For one, more 
neuroimaging studies are needed to assess how oxytocin receptors are mapped in the 
human brain. Oxytocinergic brain pathways have been better identified in rodents 
(Onaka, 2004). The expression of oxytocin receptors in specific regions of the CNS 
regulate different behaviours in rodents. In female rats, for example, estrogen-dependent 
expression of oxytocin receptors in the ventromedial nucleus of the hypothalamus 
regulates sex behaviours whereas  dopamine controlled expression of oxytocin receptors 
in the central nucleus of the amygdala regulates anxiety-related behaviours (Bale et al., 
2001). However, the physiological mechanisms regulating these behaviours may differ in 
humans. Differences between the human brain and that of other animal species need to be 
considered when translating findings from animal models to humans.   
Furthermore, there is a need to evaluate how the oxytocinergic system interacts 
with other physiological systems (i.e. neurotransmitters, corticosteroids, endogenous 
opioids) to regulate human behaviour. These interactions have received greater attention 
in non-human animals. In female prairie voles, the dopaminergic system is believed to 
interact with oxytocin in the nucleus accumbens to facilitate pair-bond formation (Young 
et al., 2001) whereas the serotenergic system is purported to influence central oxytocin 
neurotransmission at ejaculation in male rats (de Jong, Veening, Olivier, & Waldinger, 
2007).  It is posited that oxytocin’s effects on stress reactivity may also be mediated by 
complex physiological interactions. In rats, noradrenergic neurons appear to play an 
important role in modulating endogenous oxytocin responses to fear-related stressors 
(Onaka, 2004). Research in rats has further shown that exogenous oxytocin attenuates the 
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HPA axis in response to acute and chronic stressors by inhibiting mRNA expression of 
corticotropin releasing factor via gamma- aminobutyric acid receptors in the 
parventricular nucleus of the hypothalamus (Bulbul et al., 2011; Zheng et al., 2010). Of 
course, these types of interactions are difficult to study in humans due to methodological 
limitations. Unravelling these brain mechanisms in humans is therefore a feat for future 
research.  
Future research is also needed to evaluate the relationship between endogenous 
and exogenous oxytocin. It is unknown if the behavioural effects generated by exogenous 
oxytocin are the same as those produced by endogenous oxytocin. It is also unclear to 
what extent the effects of intranasal oxytocin on human behaviour are dose-dependent. A 
dose of 24 I.U. oxytocin was employed in both of our studies, which has been the most 
extensively examined in the human literature (Ditzen et al., 2009; Heinrichs et al., 2003; 
Kosfeld et al., 2005). Although smaller and larger doses of intranasal oxytocin have been 
investigated, no known study has directly examined whether behavioural effects vary as a 
function of dose.   
Dose-dependent behavioural effects of oxytocin have frequently been reported in 
animals. For instance, in female prairie voles, the administration of a low neonatal dose 
oxytocin will facilitate pair bonding in adult life whereas a high neonatal dose will inhibit 
pair bonding in adult life (Carter, Boone, Pournajafi-Nazarloo, & Bales, 2009). Rather 
than form partner preferences and long lasting pair bonds, females will avoid familiar 
partners. In male rats, low acute doses of oxytocin facilitate copulatory performance 
whereas high doses attenuate male sexual responses (Stoneham, Everitt, Hansen, 
Lightman, & Todd, 1985). Oxytocin’s impact on stress reactivity and physiological 
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arousal also appears to be dose-dependent. Windle et al. (1997) demonstrated that a low 
dose of centrally infused oxytocin had no impact on the corticosterone response to the 
stressor whereas both a moderate and high dose attenuated the response. Furthermore, in 
a fear potentiated startle paradigm, only a high dose of centrally administered oxytocin 
attenuated the startle response in rats (Ayers et al., 2011).  
Although well established in the animal literature, interpreting these dose-
dependent effects can be challenging. There is little consistency in the doses employed 
between studies and there are no standard criteria to delineate low, moderate, and high 
doses. As such, these categories are arbitrary to each study. Based on reported findings, it 
would appear that central oxytocin has no impact on the HPA axis or the acoustic startle 
response at low doses; findings that would need to be replicated in humans. Moreover, it 
is unclear whether the effects of oxytocin on a given behavior would vary linearly or non-
linearly in the form, for example, of an inverted “U” shape curve as observed in the 
relationship between glucocorticoids and cognition in humans (Lupien & McEwen, 
1997). Studies in animals indicate that oxytocin’s effects are frequently reversed when 
the dose exceeds a certain threshold. If representative of our own findings, high doses of 
exogenous oxytocin would be expected to increase cortisol levels and to heighten the 
startle response.  
It also remains uncertain how long the effects from exogenous oxytocin can be 
sustained. Does oxytocin induce long-lasting effects or are these present only under drug 
administration? Addressing this question is key in determining how effective oxytocin 
can be in the treatment of mental disorders. It is dubious whether intranasal oxytocin can 
be safely and effectively administered at high doses over long periods of time. Prolonged 
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oxytocin exposure in male rats has been shown to result in a 50% decrease in oxytocin 
receptor density in areas throughout the brain (Witt, 1997). Very few human studies have 
examined the effects of long-term oxytocin administration. Epperson et al. (1996) 
administered intranasal oxytocin over several weeks in participants diagnosed with OCD 
and reported no adverse effects associated with long-term administration and no positive 
effects on treatment outcomes either. In a case study performed in a man diagnosed with 
OCD, exogenous oxytocin, administered daily over a 4 week period appeared to alleviate 
OCD symptoms, but was also associated with severe memory disturbances (Ansseau et 
al., 1987). This study highlights the need for caution in the chronic administration of 
exogenous oxytocin. In the end, higher oxytocin doses or longer exposures to the 
hormone may not necessarily lead to greater benefits.  
In conclusion, the last decade has been privy to a dramatic increase in the number 
of studies examining the behavioural effects of oxytocin in humans. Its pro-social effects 
have generated so much interest and excitement that oxtocin has been described as a 
“love hormone” in the media (O'Callaghan, 2010).  Albeit popular, this representation of 
oxytocin is grossly oversimplified. The oxytocinergic system is complex and branches 
into many different aspects of human functioning. It can modulate stress-responsive 
physiological systems as well as social cognitive processes (i.e. learning, memory, 
empathy, emotional processing). One could argue that these functions are all intended for 
the attainment of pro-social outcomes, but this does not always appear to be the case. The 
hormone does not promote affiliative behaviours when it is maladaptive to the individual. 
As such, oxytocin might serve a greater purpose of ensuring the well-being and safety of 
humans.  
 82 
We have demonstrated that oxytocin impacts the HPA axis during interpersonal 
challenge and attenuates the basic startle reflex. By dampening these physiological 
systems, oxytocin could be serving to facilitate social approach behaviour. However, it is 
also possible that oxytocin is providing homeostasis by regulating sympathetic fight or 
flight circuits. We know that the stress response is adaptive when triggered by acute 
stressors but that it has deleterious health outcomes when over-stimulated for prolonged 
periods of time (Sapolsky, 2004). By restoring a sense of calm and safety, oxytocin could 
be mediating the beneficial effects that positive social relationships have on physical and 
mental health.  
This is one hypothesis that requires future investigation. Considering that this area 
of research is relatively new, many avenues are open for future directions. We can only 
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